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SUMMARY
This thesis describes and discusses the effects that various 
components of Bordatai Ia pertussis produce on neutrophil 
leukocytes; particularly those of the rabbit. The work was 
done with crude fractions and purified components of the 
bacterium and also whole-cells of mutant strains and of 
antigenically-modulated variants of B.pertussis .
The neutrophil functions which were investigated in detail 
were
Cl) adhesiveness, as assayed by aggregation.
CS) bactericidal response, as assayed by luminol-enhanced 
chemiluminescence, to a pro-inflammatory mediator 
CN'-formy1-L-methiony1-L-leucy1-L-phenylalanine; fMLP) 
or to intact X-mode B .pertussis Tohama.
The filamentous haemaggiutinin CFHA) of B.pertussis had at 
least four noteworthy effects on the function of rabbit 
peritoneal neutrophils: it enhanced neutrophil aggregation; it 
directly induced neutrophil chemiluminescence; it enhanced the 
neutrophil response to fMLP; and it induced a faster rate of 
chemiluminescence production to intact B .pertussis. There 
were species differences in neutrophils and FHA-enhancement of 
aggregation with rabbit neutrophils was not found with human 
or pig cells.
Lipopolysaccharide endotoxin CLPS) of B.pertussis, unlike 
FHA, had no effect on the aggregation of rabbit peritoneal 
neutrophils. However, it resembled FHA in inducing neutrophil 
chemiluminescence directly and in enhancing neutrophil 
response to fMLP. LPS from Salmonella minnesota behaved 
similarly in each of the above. B .pertussis LPS also induced a
9
faster rate of neutrophil chemiluminescence to intact
B r ps,ctyasi.a ■
Pertussis toxin CPT) enhanced aggregation of rabbit 
peritoneal and peripheral neutrophils and human peripheral 
neutrophils. It inhibited neutrophil chemiluminescent response 
to fMLP although only after a lag period of 30-40 min. PT 
overrode the enhancing effects of FHA and LPS on neutrophil 
response to fMLP. The latter observation was applied to 
monitoring the toxoiding of an experimental acellular 
pertussis vaccine, consisting predominantly of PT and FHA. PT 
slightly suppressed the neutrophil chemiluminescent response 
to intact B .pertussis .
With intact B .pertussis there was a positive correlation 
between hydrophobicity and the induction of neutrophil 
chemiluminescence.
The work supports the view that a significant feature of 
infection with B .pertussis is the ability of the pathogen to 
impair the functional effectiveness of host phagocytes.
10
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Part 1 : Bordetella pertussis
2.1.1. Taxonomu of the aenus Bordetella
The genus Bordetella has four members: B.pertussis.
B ,parapertussis. B.bronchiseotica. and the recent addition
B'Pettvasia, B,..BSrSLJasrtySLg.A.S, and s.bronchiseotica 
were first assigned to the separate genus Bordetella by 
Moreno-Lopez in 1952. Previously B .pertussis and 
B.parapertussis were classified as members of the genus 
Haemophilus. B .bronchiseotica was formerly placed successively 
in the genera Bacillus. Alcalioenes. Brucella then 
Haemophilus. B .avium was previously identified as a member of 
the Alcalioenes genus before its assignment to the Bordetella 
genus. Kersters ejt aj^ . C19B4) listed the major characteristics 
of B ,avium : Pittman and Wardlaw C19B1) described the 
characteristics of the other three members of the genus. Goodnow 
(1980) reviewed the biological properties and characteristics of 
B.bronchis e p t .i_c_a.. Both B . bronchiseotica and B . avium
are motile whereas B .pertussis and B .parapertussis are not.
Bordetella species are aerobic, gram-negative, minute, 
coccobacilli, All are pathogens of the respiratory tract;
B . pertussis and B .parapertussis cause whooping cough in 
humans, B.bronchiseotica causes respiratory infections in many 
mammalian species but only occasionally in man, and B .avium is 
a pathogen of birds.
2.1.2. Pertussis - the disease
Whooping cough, or pertussis, is an epidemic respiratory 
disease that mainly affects infants and young children. The
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disease was mentioned in 1540 by Moulton; DeBaillou Cor 
Bâillon, or Ballonius) first described an epidemic in 1570 
(cited in Lapin, 1343). The World Health Organisation 
estimates that nearly one million children still die each year 
from the disease CHinman, 1385). The incubation period for 
pertussis is considered to be 6 to 20 days, with an average of 
7 days. After the incubation stage the infection progresses to 
the catarrhal stage. The onset of this stage is non-specific 
and symptoms resemble the ones associated with an ordinary 
upper respiratory tract infection such as coughing, sneezing, 
and oedema of the eyelids. In some cases slight fever may also 
occur. As the disease progresses the symptoms continue to 
worsen with coughing becoming more frequent and more violent. 
After one to two weeks the paroxysmal stage gradually 
supervenes. During this stage the patient suffers severe bouts 
of coughing or occasionally fits of sneezing. The 
characteristic whooping noise associated with pertussis occurs 
when, after a bout of paroxysmal coughing, inspiration ensues 
through the partially swollen pharynx into the lungs. At the 
end of a paroxysm a patient will often vomit, which together 
with the severe coughing bouts, interferes with the patient's 
nutrition and fluid intake. The physical exertions of coughing 
may also cause various damaging effects such as conjunctival 
haemorrhage, hernia, emphysema, and pneumothorax.
Complications include damage to the central nervous system 
which may occur following cerebral anoxia and haemorrhage 
induced by the paroxysmal coughing CLinneman, 1373). 
Encephalopathic states may occasionally occur although the 
reasons have not yet been established (Joint Committee on 
Vaccination and Immunisation, 1301).
Superinfection of pertussis patients can occur and may lead
12
to primary or secondary bronchopneumonia. The bacteria most 
often involved are encapsulated organisms such as
Streptgçgçgus. pngumgpisg., Haemgahilus influenzae, and 
pathogenic staphylococci (Jamieson, 1973). Olson (1975) and 
Manclark and Cowell (1984) reviewed pertussis and its 
sequelae.
The convalescent stage of pertussis is characterised by 
coughing episodes of diminished frequency and severity. Cases 
of reinfection with the redevelopment of pertussis have been 
reported (Wilson et. al_. , 1965) . The susceptibility of 
pertussis patients to secondary infections and the afebrile 
responses usually associated with the disease suggests that 
the host’s normal inflammatory responses and immune system may 
be altered by B .pertussis infection.
2.1.3. Pertussis vaccine and vaccination
The preparation of a pertussis vaccine was first made 
possible in 1906 when the organism was isolated and grown on 
laboratory medium (Bordet and Gengou, 1906). Vaccines prepared 
in the 1920s and 1930s gave inconsistent results with some 
investigators finding a correlation with immunisation and 
protection against disease whereas others did not. Manclark 
and Cowell (1984) reviewed the early history of pertussis 
vaccine and vaccination. The reasons for these inconsistencies 
were probably due to differences in the methods used to 
inactivate the bacterium and to reduce its toxicity and the 
absence of a standard method for measuring vaccine potency or 
toxicity. The latter problem was solved when clinical trials 
in the 1940s and 1950s related efficiency of whole-cell 
pertussis vaccines with potency in the intracerebral mouse
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protection test (Kendrick gl., 1947; Armitage et al.., 1956).
Pertussis vaccines in current use are either of the 
whole-cell type or the acellular type. Whole-cell vaccines 
were first used in the 1920s while an acellular pertussis 
vaccine was first used in trials in the late 1950s (Armitage 
et al., 1959). The majority of the whole-cell vaccines in 
current use consist of B .pertussis cells that have been killed 
by treatment with formaldehyde, thiomersal, heating at 5G°C, 
or by a mixture of heat and chemicals. Most of the recent 
studies concerned with the development of an acellular vaccine 
have involved the isolation and purification of the major 
haemagglutinins of B .pertussis. An acellular pertussis vaccine 
in current use in Japan consists of formalin-detoxified 
pertussis toxin and filamentous haemagglutinin, a trace amount 
of other B .pertussis proteins, reduced amounts of LPS, and 
aluminium hydroxide as an adjuvant (Sato e;t a_l. , 1984) . A 
noticeable omission from the Japanese vaccine is the 
heat-labile agglutinogens. Various studies have indicated that 
these agglutinogens may be important components of whole-cell 
vaccines (Armitage et, aX-, 1356; Preston, 1963; Preston and 
TaPunga, 1953) and their inclusion in an acellular vaccine for 
USB in the U.K. is under investigation; field trials are 
currently being performed. Robinson a_l_. (1985) reviewed 
progress towards the development of improved acellular 
pertussis vaccines.
Pertussis vaccine can be given alone or in a triple vaccine
(DPT) which also contains diphtheria and tetanus toxoids and
the adjuvant aluminium hydroxide (Butler at , 1969). The
vaccination schedule in current use in the U.K. advocates a
series of three DPT injections, with an interval of 6-8 weeks
between each, to be given to children aged 3-6 months old
14
CJoint Committee on Vaccination and Immunisation, 19B1). A 
booster DTP injection is then given once the child is five 
years old.
The antibiotic erythromycin can be used in the treatment of 
pertussis since B.pertussis is susceptible to this drug (Bass 
et a l ., 1969). Pertussis antiserum is also available although 
no evidence exists to prove that it is effective in preventing 
pertussis (Morris and McDonald, 1957).
The USB of effective pertussis vaccines has contributed 
greatly towards the decline in incidence of the disease. The 
relatively low incidence of pertussis at present has given 
rise to the opinion held by some that the well-publicised side 
effects of the vaccine may constitute a greater risk than the 
disease (Dick, 1974; Stewart, 1905). Risks associated with 
pertussis vaccine include local reactions such as redness and 
swelling; systemic reactions such as fever, vomiting and 
diarrhoea; and rare but serious neurological reactions. A 
study in the U.K. estimated that the risk of neurological 
illness attributed to DTP vaccine was 1 in 110,000 
vaccinations (Joint Committee on Vaccination and Immunisation, 
1981). However, the report also reaffirmed that pertussis 
vaccine is effective against pertussis and suggested that the 
advantages of the vaccine in preventing pertussis outweighed 
the risks associated with its use.
2.1.4. Bioloaicallu-active components of B.pertussis
Bordetella pertussis produces a wide range of 
biologically-active components that may individually or in 
conjunction with other components be important in the
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pathogenesis of disease and in immunity. These components are 
reviewed briefly. The articles of Munoz and Bergman (1377), 
Wardlaw and Parton (1903), Manclark and Cowell (1904), and 
Robinson gt al., (1905) give a more detailed consideration of 
individual B .pertussis components.
(a) Adenulate cuclase
B .pertussis adenylate cyclase activity was first observed in
the supernate of a whole-cell pertussis vaccine (Wolff and
Cook, 1973). Adenylate cyclase was later purified from
B ■pertussis culture supernates and characterized by Hewlett
and Wolff (1976). The purified enzyme was heat-labile (90%
activity lost after 20 min at 5B°C), required Mg=^ for
maximal activity, and had a molecular mass of 70 kDal. Hewlett
gi. al_. (1976) also reported that the enzyme was
extracytoplasmic. Paradoxically, Confer and Eaton (1902) have
reported that urea-extracted adenylate cyclase from
B .pertussis was heat-stable; the enzyme resisted heating at
100°C for 5 min. B .pertussis adenylate cyclase is stimulated
by calmodulin; a Ca^^-binding protein found in most, if
not all, eukaryotic cells (Wolff et, a4., 1900; Goldhammer et
Sjl.. , 1901). Greenlee et gX, (1902) estimated the molecular
mass of adenylate cyclase to be 77 kDal and noted that
calmodulin stimulated adenylate cyclase both in the presence
and absence of free Ca*’*'. The lower molecular mass adenylate
cyclase, isolated by the technique of Hewlett and Wolff
(1976), was not stimulated by calmodulin perhaps because of
partial proteolytic degradation, which would account for its
insensitivity to calmodulin stimulation (Greenlee et al_. ,
1902). A second form of adenylate cyclase was reported by
IB
Wolff at al_. (1984). This enzyme was isolated from intact 
B.pertussis, had a molecular mass of 47 kDal and was 
stimulated by calmodulin even in the absence of free Ca=*.
Speculations concerning the exact role of the B.pertussis 
adenylate cyclase have been made since its first isolation 
(Hewlett and Wolff, 1976). Brownlie ejt (1905) showed that
B.pertussis adenylate cyclase is not involved in regulating 
the synthesis of virulence-associated proteins. 
Transposon-induced mutants of B .pertussis that were deficient 
in both adenylate cyclase and haemolysin were avirulent in a 
mouse respiratory infection model (Weiss et gjL_. , 1904). The 
interaction of B .pertussis adenylate cyclase with phagocytes 
is reviewed in section 2.3.2.
(b) Filamentous haemaoplutinin
Haemagglutinating activity of B .pertussis was first reported 
by Keogh at, aJL. (1947). Arai and Sato (1976) later 
demonstrated that B .pertussis actually produces two 
haemagglutinins: one designated fimbrial haemagglutinin and 
the other leukocytosis-promoting factor haemagglutinin. The 
former haemagglutinin had a filamentous structure 
(approximately 2 by 40 nm), had no histamine-sensitizing 
activity in mice, and was once thought to be associated with 
the fimbriae. However, other studies have indicated that this 
haemagglutinin is not associated with fimbriae (Ashworth gjt 
al. , 1982b) and it is now usually referred to as filamentous 
haemagglutinin (FHA) . Early work by Fisher (1949) indicated 
that cholesterol may be important in B .pertussis 
haemagglutinin interaction with erythrocytes and liposomes 
containing cholesterol were later used as a means of achieving
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purification of FHA (Irons and MacLennan, 1979). FHA has been 
purified by various techniques and estimates of its molecular 
mass and subunit structure vary widely (Aral and Sato, 1976; 
Irons and MacLennan, 1979; Cowell e^ al.. , 1982). SDS-PAGE 
analysis of FHA shows multiple polypeptides with molecular 
mass from 220 to 58 kDal. Studies using monoclonal antibodies 
indicate that the lower molecular mass bands were probably 
fragments of the high molecular mass polypeptide (Irons et 
al. . 1383). FHA production is favoured in static, 
poorly-aerated conditions (Arai and Munoz, 1979) or in shaken 
cultures containing heptakis (2,B-O-dimethy1)beta-cyclodextrin 
(Suzuki et^  gl.. , 1985) .
The importance of FHA in pathogenesis of B .pertussis has 
been shown in various studies. Antibodies against FHA protect 
mice from intranasal infection by B .pertussis. suggesting that 
immunity to FHA is important in immunity to the disease (Sato 
gt. aj,,. , 1981). Absence of FHA from the organism has been 
associated with loss of adherence to human ciliated 
respiratory epithelial cells jji vitro (Tuomanen and Weiss, 
1905). FHA may also function as an important adhesin in vivo . 
The interaction of FHA with phagocytes has not been reported.
(c) Haemolusin
Haemolysin production is characteristic of virulent 
B . pertussis and is readily lost on sub-culture jjn vitro 
(Lautrop, 1960). Genetic studies indicated that mutants 
deficient in both haemolysin and adenylate cyclase have 
reduced virulence in the mouse respiratory infection model 
(Weiss ejt g_L. , 1984), The exact role of the haemolysin in
infection is unknown.
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(d) Hgati7l9bjLIa...-aa,fljLmtAuQfle.DS
The agglutinogens of B .pertussis can be defined as surface 
antigens which stimulate the production of antibodies which 
will in turn cause bacterial cell agglutination. The 
agglutinogens were first described by Andersen (1953) and 
later classified using the numbers 1 to 14 by Eldering et a l . 
(1957). Eight agglutinogens were proposed for B.pertussis: 1-7 
and 13. Agglutinogens 1 and 7 were found in all strains of 
B^pertussls with factor 7 being common to all Bordetella 
species. Some of the early methods of purification of 
agglutinogens are summarized by Munoz and Bergman (1977). Both 
agglutinogens B and 3 have recently been purified and reported 
to have a subunit molecular mass of 22 kDal (Zhang e^ ,
1985) and 20.B kDal respectively (Fredriksen gt_ al.. , 1905). 
Although the agglutinogens are generally thought to be 
envelope antigens, recent work has indicated that some are of 
fimbrial origin (Ashworth et al,. , 1902b; Carter and Preston,
1904).
Antibodies against agglutinogens may be important in 
immunity to pertussis (Preston and TePunga, 1959; Preston, 
1963). Current WHO recommendations are that vaccines should 
include the three major agglutinogens (1, 2, and 3).
(B) Heat-labile toxin (Dermonecrotisina toxin)
This was first reported by Bordet and Gengou (1909) who 
described a heat-labile substance of B .pertussis which was 
lethal to guinea-pigs and rabbits when given intraperitoneally 
or intravenously and dermonecrotising when given 
subcutaneously. A heat-labile product of B .pertussis also
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induces splenic atrophy in mice Clida and Dkonigi, 1971) and 
is cytotoxic to cell cultures (Felton gt. al.. , 1954). The 
dermonecrotising activity of B.pertussis is destroyed by 
heating at BO°C for 10 min (Munoz et. al.- , 1959) . The 
instability of the toxin has been a major impediment to its 
isolation and subsequent purification. Properties of 
partially-purified toxin preparations have been reported
(Onoue et, al.* . 1963; Nakase gj^  al. , 1969). The preparation 
of Livey and Wardlaw (1984) had a molecular mass of 
approximately 90 kDal. Nakase and Endoh (1905) reported the 
isolation of purified heat-labile toxin which had a total 
molecular mass of 102 kDal and consisted of two polypeptides 
of molecular mass 30 kDal and 24 kDal . When administered 
intracutaneously into guinea-pigs and mice the purified toxin 
induced vasoconstriction which subsequently resulted in 
necrosis and haemorrhage. In addition, the toxin appeared to 
inhibit rat kidney Na+ - K+ ATPase in vitro. Inhibition of 
this enzyme may cause constriction of vascular smooth muscle 
and this action may explain the ability of the toxin to induce 
dermonecrosis and splenic atrophy in mice (Nakase and Endoh,
1905), Kume et. gl. (1906) reported the purification of 
heat-labile toxin from Bordetella bronchiseotica. This 
preparation had a molecular mass of about 190 kDal and 
dissociated into two components of molecular mass about 110 
kDal and 75 kDal after treatment with dithiothreitol and urea. 
Heat-labile toxin is an intracellular protein although small 
amounts may be detected extracellularly (Banerjea and Munoz, 
1962; Cowell et. gl_. , 1979). The exact role of heat-labile 
toxin in pathogenesis is at present unknown.
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Cf) Lipopq1usaccbaridB andgtoxin
B .pertussis is unusual in that it has two chemically 
distinct forms of lipopolysaccharide endotoxin (LPS), termed 
LPS-I and LPS-II, which differ in their polysaccharide 
components (Le Dur at. ai.-> 1900). Both LPS-I and LPS-II appear 
to have similar biological properties to those of the 
unfractionated LPS preparation. B .pertussis LPS has 
properties similar to the LPSs of other gram-negative bacteria 
(Nakase et gl. , 1970; Ayme at al.-, 1900). It is unusual, 
although not unique, in being mitogenic for murine spleen 
cells (Girard at. ai.-, 1901). Polyclonal activation of rabbit 
immunoglobulin-forming cells by B.pertussis LPS is 
macrophage-dependent (Haeffner-Cavaillon et. ai. , 1902a) and 
B . pertussis LPS binds specifically to rabbit peritoneal 
macrophages (Haeffner-Cavaillon et ai., 1902b). B.pertussis 
LPS may also have adjuvant activity (Morse 1976; Ayme at ai. , 
1980), Aprile and Wardlaw (1973) reported that different 
strains of B .pertussis had different LPS antigenic 
determinants although other studies failed to confirm this (Le 
Dur et ai., 1900).
(g) Pertussis toxin
Nomenclature
B , D er t_ys_g i s produces a toxin which appears to be the major 
virulence factor of the organism (Pittman, 1979). The diverse 
biological activities of this toxin are reflected in the 
different names assigned to it. The concept that these various 
activities may actually be attributable to the one substance
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was first stated in the Unitarian Hypothesis of Levine and 
Pioroni C19B6). The name pertussigen was later used by Munoz 
(1976) for a substance, which among other activities, 
sensitized mice to histamine and induced leukocytosis. Wardlaw 
and Parton (1983) reviewed the evidence for and against the 
pertussigen concept. A factor isolated from B.pertussis. 
termed islet-activating protein, had histamine-sensitizing 
activity and leukocytosis-promoting activity (Mizushima at 
al. ■ 1979). Pittman (1979) first used the term pertussis 
toxin for a substance which had histamine-sensitizing, 
leukocytosis-promoting, and islets-activating activity. To 
avoid confusion, I propose to use the term pertussis toxin 
(PT) for a substance which has the biological activities 
listed below and the other properties attributed to the 
pertussigen molecule in Wardlaw and Parton (1903). Before a 
review of some of the more important biological activities of 
PT, the physicochemical properties and ADP-ribosylating 
activity of the molecule will be briefly discussed.
E.l3.u.slcgc?l)gci.i,gaX prppgr.tig,^
PT has been purified by various investigators although, as 
mentioned previously, the product may have been called by 
another name. Estimates of the molecular mass of the toxin are 
summarised in Table 1.
The subunit structure of PT has also been variously 
estimated. The purified islets-activating protein (lAP) of 
Yajima et gi.. (1970a) consisted of four polypeptide chains of 
molecular mass IE, 20, 20, and 25 kDal. Irons and MacLennan
(1979) purified the lymphocytosis-promoting factor 
hemagglutinin which consisted of four component polypeptides
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l9bJ,e I.
Estimates of the molecular mass of pertussis toxin
Authors' Molecular
Reference designation mass
of substance* (kDal)
Lehrer at al. (1974) HSF 90
Arai and Sato (1976) HA-LPF 107, 103, 30
(by different methods)
Morse and Morse (1976) LPF 67-74
Yajima et al. (1979a) lAP 77
Cowell at al. (1392) LPF-HA 170
Tamura et al. (1992) lAP 117
Sekura et, al. (1903) Pertussis toxin 113
Nicosia et (1906) Pertussis toxin 109
^HSF^Histamine-sensitizing factor,
HA-LPF^Hemagglutinin-leukocytosis-promoting factor, 
LPF=Lymphocytosis” (or leukocytosis-) promoting factor,
IAP=Islet(s)-activating protein, LPF-HA=Leukocytosis-promoting 
factor-hemagglutinin.
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of molecular mass 12.G, 21.1, 22.4, and 27.2 kDal. The 
purified lAP of Tamura gl. jgl. C19B2) consisted of six 
subunits, one copy of subunits 1, 2, 3, and 5 and two copies 
of subunit 4. The molecular mass of the subunits were 20, 23, 
22, 3.3, and 11.7 kDal respectively. Sekura @1 §^ 1. C10B3) 
proposed slightly different molecular masses for the subunits 
but agreed that PT consists of six subunits. Using genetic 
techniques the PT genes have now been cloned and sequenced 
CLocht and Keith, 1906; Nicosia at. gl., 1906). The cloned 
toxin has a deduced molecular mass of about 109 kDal.
PT is an A-B type toxin. The B-oligomer of the toxin 
comprises subunit 5, a dimer of subunit 2 and 4, and a dimer 
of subunit 3 and 4. Subunit 1 is the enzymically-active A 
component (Tamura et al_. , 1902) .
ADP-ribosulatino activltu
The A-protomer of PT catalyzes the ADP-ribosylation of a 
membrane-bound protein of molecular mass 39-41 kDal in target 
cells (Tamura at. , 1902) , The toxin substrates include 
the guanine nucleotide binding proteins (B-proteins) B i , Go, 
and transducin (Milligan at §1.., 1905). The major PT 
substrate of CB glioma calls modulates adenylate cyclase 
activity causing receptor mediated stimulation of cAMP 
accumulation (Katada and Ui, 1902). PT also ADP-ribosylates a 
membrane protein in neutrophils causing an inhibition of 
normal response to chemotactic factors, however, the basal 
cAMP levels in these cells remains unaffected (Bokoch and 
Gilman, 1904; Okajima and U i , 1904). There is now evidence to 
suggest that the PT substrates of both CB glioma cells and 
neutrophils are G-proteins immunochemically distinct from G i ,
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Go, or transducin (Milligan gt. aJL* , 190B; Gierschik st al . .
1980).
Pa tQti b io lO Q lea l „a c t iv it la s .
The major activities of PT are reviewed below. The effect 
of PT on phagocytes is covered in section 2.3.3. Munoz and 
Bergman (1977), Wardlaw and Parton (1903), and Sekura eJt a l . 
(1905) reviewed the different biological properties of P T . 
These articles also cover activities of the toxin such as 
toxicity, adjuvancy, mitogenicity, and the ability to confer 
protection in the murine intracerebral challenge test. Due to 
the constraints of a review such as this, these activities are 
not covered below.
Haemaaalutination
Arai and Sato (1376) first demonstrated that B . pertussis 
actually produced two haemagglutinins. One (FHA) was non-toxic 
in mice whereas the other was toxic, induced histamine 
sensitivity and leukocytosis in mice, and was termed the 
leukocytosis-promoting factor hemagglutinin (LPF-HA). 
Differentiation of the two haemagglutinin types can be done 
using the physical character of the erythrocyte agglutination 
they produce. LPF-HA produces firmly-bound, coherent sheets of 
agglutinated erythrocytes whereas FHA appears to influence 
only the settling of the erythrocytes. The most sensitive 
erythrocyte species to agglutination by LPF-HA are goose 
erythrocytes (Irons and MacLennan, 1979).
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Hlstamine-sensxtizatipn
B.pertussis histamine-sensitizing activity was first 
described by Parfentjev and Goodline (1348). Pertussis vaccine 
injected intraperitcneally into mice made the animals 
hypersensitive to a subsequent injection of histamine. The 
term histamine-sensitizing factor (HSF) was first proposed by 
Maitland gt (1355). HSF also increases susceptibility to
the effects of serotonin, bradykinin, and a variety of other 
stress stimuli (Munoz and Bergman, 1968). The exact mechanism 
of histamine-sensitization in mice remains unknown. However, 
histamine-sensitization is an activity of the B-oligomer of PT 
(Nogimori gt al_. , 1984) .
Islets-activation
A tendency towards hypoglycaemia during or after infections 
with B .pertussis has been observed both in children (Regan and 
Tolstoouhov, 1936) and experimental animals (Oddy and Evans, 
1940; Pittman gt gl_. , 1980). Pertussis vaccine causes 
hyperinsulinaemia in rats (Gulbenkian et gl. , 1560). Studies 
have correlated the hyperinsulinaemia with the time-course of 
hypoglycaemia in the same animals suggesting that both effects 
are linked (Tabachnick and Gulbenkian, 1969). Similar effects 
were noted with the purified lAP of B .pertussis by Yajima et 
âl.' (1970 a, b) . lAP exerts its effects by acting on the 
pancreatic islet B-cells, blocking the inhibition of insulin 
release. This suggests that the hypoglycaemia associated with 
B ,pertussis infections is probably due to an lAP-induced 
alteration in the pancreatic B-cells leading to hypersecretion 
of insulin in response to various insulin-releasing stimuli
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CKatada and U i , 1979; Katada and U i , 1980).
LeuKflcubpgXs DromotiGO.
The lymphocytosis Frequently observed in whooping cough 
patients was first reported by Frolich in 1897 (cited by 
Wardlaw and Parton, 1983). Sauer (1933) noted the occurrence 
of lymphocytosis in children injected with pertussis vaccine. 
The factor responsible for these effects has been designated 
leukocytosis-promoting factor and lymphocytosis-promoting 
factor, both abbreviated to LPF. The blood counts of both 
lymphocytes and polymorphonuclear leukocytes are increased by 
pertussis or purified LPF-treated animals (Morse, 1965; Morse 
and Morse, 1976). Morse and Reister (1967) indicated that the 
lymphocytosis observed in pertussis-treated mice was not due 
to stimulation of cell division but rather blockade of 
lymphocyte recirculation from the bloodstream back to 
extravascular sites. Also the neutrophilia appeared to be due 
to active cell proliferation as well as neutrophil migration 
into the bloodstream from tissue reserves. Lymphocytosis may 
be induced by a change in lymphocyte rather than vascular 
endothelial cell properties (Morse and Barron, 1970), 
Spangrude gt al.. (1984) found that pertussigen-treated 
murine lymphocytes lost their ability to localize in lymph 
nodes or Peyer’s patches. Adherence of the lymphocytes to 
endothelial cells in. vitro was unaffected. Lymphocyte 
extravasation may involve a receptor-specific binding event 
followed by an adenylate cyclase-dependent activation of cell 
motility. PT may inhibit the second process thus explaining 
its capacity to block lymphocyte recirculation iri vivo 
(Spangrude gt al., 1984).
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Ch) Tracheal cutotoxln
B .pertussis has the ability to adhere to and destroy both 
hamster tracheal organ and epithelial calls irj. vitro 
(Collier gL al., 1977; Goldman et gl. , 1982). Culture 
supernates From virulent B .pertussis cultures appear to 
inhibit DNA synthesis in uninfected tracheal cells in. vitro. 
The substance responsible was designated tracheal cytotoxin 
and the purified product appeared to consist of a peptide^of 
molecular mass 1.5 kDa^, muramic acid and glucosamine (Goldman 
gL al. , 1902). The exact structure of the toxin and its role 
in virulence remains unknown.
2.1.5. Phase variation and antigenic modulation
Bordetella species can undergo a form of variation termed 
phase variation (Leslie and Gardner, 1931). Freshly isolated 
and undegraded strains of B .pertussis are termed phase I 
organisms; completely degraded, antigenically changed, 
avirulent strains which appear on prolonged subculture are 
termed phase IV organisms. Phase II and phase III strains are 
intermediate forms between phase I and phase IV organisms. 
Factors lost during change from phase I to phase IV include 
HSF (Kind, 1953), agglutinogen 1 (Eldering gt al-, 1962), 
haemagglutinating activity (Keogh and North, 1948; Standfast, 
1951), haemolysin (Peppier, 1902), and certain envelope 
proteins (Parton and Wardlaw, 1975; Ezzell gt gl.. , 1981). 
Increased tolerance to erythromycin was used by Weiss and 
Falkow (1904) as an avirulent-phase marker. They found that 
avirulent phase organisms failed to produce PT, FHA or 
haemolysin.
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Although phase variation was thought to be essentially 
irreversible (Parker, 1979), recent studies have indicated 
that phase variation may be reversible and is possibly 
regulated by the production of a positive effector protein 
which switches on the virulent phase genes (Weiss and Falkow, 
1984).
Bordetella species can also undergo another kind of 
variation termed antigenic modulation. The organism may be 
classified into three different modes: xanthic (X)-mode, 
cyanic (C)-mode, or intermediate-mode (Lacey 1951, I960). When 
NaCl was replaced by MgSO* as the principal salt in a solid 
medium devised by Lacey, B .pertussis colonies lost 
agglutinogens, haemagglutinating and haemolytic activity, and 
had decreased virulence in mice. The NaCl-grown bacteria were 
designated X-mode and the MgSO*-grown bacteria were designated 
C-mode. Lower temperatures favour C-mode growth and higher 
temperatures favour X-mode growth. Later studies showed that 
C-mode bacteria were deficient in protective antigen, HSF, and 
two major outer membrane polypeptides of molecular mass 20 and 
30 kDal, (Parton and Wardlaw, 1975, Wardlaw et. aj^ . , 1976).
In addition, heat-labile toxin and adenylate cyclase are lost 
during X- to C-mode modulation (Livey et al., 1978; Parton 
and Durham, 1978). Pyridines and related compounds also affect 
antigenic modulation (Schneider and Parker, 1982). Idigbe 
al. (1981) found that the loss of X-mode components during 
modulation occurred within 10 hours. Genetic studies have 
indicated that antigenic modulation may be governed by the 
same genetic locus as phase variation (Weiss and Falkow,
1984).
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Part 2 : Neutrophils: activities and Functions
To appreciate the implications of the effects B.pertussis 
may have on neutrophils, their activities and functions 
must be understood. Murphy (1976) and Smith and Lumsden (1903) 
give a good coverage of neutrophil activities. Neutrophils are 
complex cells that have a wide range of activities which may 
be subdivided into four processes: adhesion, locomotion, 
phagocytosis and killing of microorganisms. Although these 
activities can be treated as separate they are all part of an 
ongoing process which usually culminates in destruction of 
foreign material in the host. Therefore, for example, an agent 
which inhibits adhesion may also prevent normal locomotion and 
an agent which inhibits phagocytosis may also inhibit killing 
of microorganisms.
2.2.1. Classification
The white cells of blood, leukocytes, can be divided into 
mononuclear and polymorphonuclear forms. Depending on the 
affinity of their cytoplasmic granules for certain acidic and 
basic dyes used in stains, the polymorphonuclear cells Cor 
granulocytes) can be classified as neutrophils, basophils, or 
eosinophils. The mononuclear forms are further subdivided into 
monocytes and lymphocytes and can be distinguished by staining 
and nuclear shape; monocytes have characteristic kidney-shaped 
nuclei. Monocytes leave the bloodstream and enter the tissues 
where they undergo morphologic and biochemical modifications 
and become resident or wandering macrophages. The role of 
macrophages in the immune response was reviewed by Kende 
(1982) and Takemura and Ulerb (1984), Neutrophils are the most
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common leukocytes in the blood CBO-70%) with the lymphocytes 
being the second most common (20-30%). The most active 
phagocytic cells are the neutrophils, monocytes, and 
macrophages (Ryan and Majno, 1977; Van Furth gi. , 1973).
The eosinophil also has phagocytic activity although it does 
not appear to be as efficient as neutrophils at ingestion and 
killing of bacteria (Yazdanbakhsh gt gl_. , 1906) . Mahmoud et 
al. (1979) reviewed the role of eosinophils in the immune 
process.
2.2.2. Adhesive properties
Neutrophils are found in the blood as circulating 
non-adherent cells, however, their role in many pathological 
processes is to leave the bloodstream and migrate into damaged 
or infected tissues (Van Furth and Willemze, 1979). During the 
early parts of the inflammatory response neutrophils begin to 
adhere to the endothelium of the post-capillary venules, a 
process called margination (Beesley gt al.. , 1978; Hoover at 
al ■ , 1978). The apparent predilection of neutrophil adhesion
for postcapillary venules may be related primarily to shear 
forces; the postcapillary venule is the site of the first 
major decrease in vessel wall shear stress (Mayrovitz gt al.. , 
1977). However, changes in neutrophil adhesiveness may also be 
important in margination (Lackie, 1982). After margination, 
the cells leave the bloodstream and emigrate towards the 
damaged or infected tissue, a process called diapedesis. Cell 
movement during diapedesis involves the locomotory machinery of 
the cell and the continual making and breaking of adhesive 
contacts between the cell and its substratum (Snyderman and 
Goetzl, 1901). Under conditions of either excessive
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adhesiveness or non-adhesiveness neutrophils fail to 
translocate (Keller gfc. aJL. , 1973; Smith gi. al.-. 1979).
Several syndromes have been associated with abnormal 
neutrophil adherence; decreased granulocyte adherence has been 
linked with post-streptococcal glomerulonephritis (Ruley gt. 
aJL., 197Ë) and multiple myeloma CSpitler si al.. , 1975) while 
increased granulocyte adherence has been linked with acute 
inflammatory disease (Lentnek gi gi. , 1976; Smith et al..
1981).
Secondary granule contents of neutrophils, such as the 
acidic proteins (Bockenstedt and Goetzl, 1980) and lactoferrin 
(□seas et gi., 1901), may play a role in mediating cell 
adherence. Wright and Gallin (1979) reported that exocytosis 
of secondary granules occurred during human neutrophil 
adherence in. vitro and during exudation rn vivo. However, 
other studies indicated that neutrophil adhesion may not be 
mediated by the contents of the secondary granules. For 
example, Gallin gt al.. (1982) reported that neutrophils 
from a patient with a congenital deficiency of secondary 
granule contents marginated normally in. vivo in response 
to endotoxin infusion and aggregated normally in response to 
the chemotactic agent
N ’-formyl“L-methionyl-L-leucyl-L“phenylalanine (fMLP). In 
addition, Boxer al.. (1902) found that fMLP induced normal 
aggregation of lactoferrin-deficient neutrophils. However, 
small amounts of lactoferrin (4-8% of normal) were still 
present in both neutrophils from the patient with the 
secondary granule content-deficiency and from the patient with 
the lactoferrin-deficiency. These low lactoferrin levels may 
still have been enough to promote adhesion and aggregation.
English and Gabig (1906) reported that cellular metabolism
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may only be required for the initial promotion of neutrophil 
adhesion while other factors may bo more important in the 
maintenance of adhesion. They found that the stimulation of 
human neutrophil adherence by phorbol myristate acetate could 
be functionally separated into an induction phase, which 
required cellular metabolism, and a Mg=*-dependent maintenance 
phase, that was independent of cellular metabolism. Neutrophil 
membrane glycoproteins may also play an important role in 
neutrophil adhesion CKobayashi gt gl.. , 1984). Congenital 
defects in neutrophil adhesion have been correlated with the 
absence of one or more high molecular mass glycoproteins, such 
as glycoprotein gplBO (Arnaout et. gl., 1982) or glycoprotein 
gplB3 (Anderson gt al_. , 1984) .
2.2.3. Locomotion and chemotaxis
Neutrophil movement towards an inflammatory focus is an 
essential part of the acute inflammatory response and any 
defects, either inherent or induced, are likely to have 
serious effects on the host defence system. An extensive list 
of clinical conditions associated with defective neutrophil 
locomotion reflects this importance (Gallin gt , 1980;
□uie and Cates, 1977). Neutrophils move over surfaces by the 
use of traction gained from adhesive contacts (Lackie, 1982). 
In situations where adhesion is poor, such as in 
three-dimensional matrices of collagen, it has been suggested 
that neutrophils may use pseudopodia to link round tissue 
fibres and then use leverage to pull the cell in a specific 
direction (Brown, 1902).
Neutrophil movement is of obvious importance in neutrophil 
chemotaxis where the cell reacts to a chemical concentration
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gradient by directed locomotion along the axis of the gradient 
(Keller gt aJL- , 1377) . The metabolic processes which occur 
to transfer the chemotactic signal into directed movement are 
complicated (Becker, 1380; Snyderman and Goetzl, 1881). The 
nature of chemotactic factors and the regulation of specific 
chemotactic factor receptors were discussed by Wilkinson 
(1881) and Zigmond and Sullivan (1981). Wilkinson (1982) 
reviewed the chemotaxis of leukocytes with emphasis on the 
inflammatory process.
Chemotactic factors which have been studied include the 
complement factors (C3b, C5a), leukotrienes, the peptide fMLP 
and IgG immune complexes. In general, most chemotactic factors 
can modulate other functions as well as chemotaxis (Romeo,
1982) and these factors are perhaps better termed 
pro-inflammatory mediators. Table 2 lists the neutrophil 
functions induced by fMLP and other formy1-methionyl peptides, 
CSa, and certain other pro-inflammatory mediators. Wilkinson
(1980) reviewed the effects of certain microorganisms on 
phagocyte locomotion. Bacterial virulence factors which 
inhibit neutrophil chemotaxis include cholera toxin 
(Roch-Arveiller gt al. , 1979) and LPS (Hartiala gt gl_. , 1985).
2.2.4. PhaoDcutosis
The microbicidal activity of neutrophils is dependent upon 
two important processes which precede intracellular killing; 
opsonization and phagocytosis. Opsonins were first described 
by Wright and Douglas in 1903 as factors which convert 
bacteria into "ready prey" for phagocytes. B .pertussis has 
low susceptibility to surface phagocytosis by human 
neutrophils. However, after the addition of IgG antibodies
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Tsbis g
The effects of fMLP, C5a and certain other pro-inflammatory 
mediators on neutrophil function*.
1. Stimulation of locomotion
a. Chemotaxis
b. Chemokinesis
2. Stimulation of secretion of lysosomal enzymes
3. Stimulation of "respiratory burst”
a. Superoxide generation
b. Hexose-monophosphate shunt activity
c. Increased Oz consumption
d. Increased HzOz formation
e. Increased luminescence
4. Induced aggregation
*Modified from Becker (1380).
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specific for the bacterium, opsonization and subsequent 
increased phagocytosis occurred CUtsumi gt §2.. , 1970) .
Currently the immunoglobulins and the complement system are 
regarded as the most important serum opsonins for promoting 
phagocytosis of microorganisms.
Although phagocytosis may be divided into attachment and 
ingestion phases, attachment of a bacterium does not 
necessarily lead to subsequent ingestion CDensen and Mandell, 
1970; Horujitz and Silverstein, 1900). Ingestion of particles 
may be by a "zipper mechanism” (Griffin et g2* , 1975) which 
appears to involve both complement and Fc receptors on the 
neutrophil cell membrane (Horwitz, 1982). Van Oss st al .
(1975) and Stendahl (1383) indicated that the size, shape, 
charge, hydrophobicity, and chemical composition of a particle 
influence its susceptibility to phagocytosis. Horwitz (1982) 
reviewed the congenital and acquired defects in phagocytosis 
and some of the bacterial substances which interfere with the 
phagocytic process.
2.2.5. Microbicidal activitu
When microorganisms bind to the surface of neutrophils and 
ingestion begins, several mechanisms that result in 
destruction of the ingested microorganism are activated. These 
mechanisms involve two major events: (i) the fusion of the
cytoplasmic granules of the neutrophil with the plasma 
membrane and the subsequent delivery of the granule contents 
into the phagosome, a process termed degranulation (Hirsch and 
Cohn, I960; Zucker-Franklin and Hirsch, 1964), and (ii) the 
generation of highly toxic products of oxygen reduction in a 
process termed the "respiratory burst” (Babior, 1370). The
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respiratory burst does not require either phagocytosis or 
degranulation but simply a contact between the phagocyte and 
stimulating agent CCurnutte aJt. ai... 1979). It is the action 
of both the granule contents and the products of the 
respiratory burst that causes the actual killing and digestion 
of microorganisms.
Bainton and Farquhar (1966) first reported that neutrophils 
contain two forms of granule: the primary or azurophil granule 
and the secondary or specific granule. Azurophil granules 
contain myeloperoxidase and various hydrolytic enzymes that 
break down organic material. In addition, they contain some 
non-enzymic materials, such as the cationic proteins COdeberg 
and Olsson, 1975), which may have important anti-bacterial 
activities. Lysozyme is found in both the azurophil and 
specific granules. Murphy (1376) reviewed the contents of 
neutrophil granules. The specific granules of human 
neutrophils contain the high affinity iron-binding protein 
lactoferrin (Masson elt , 1969) . Lactoferrin is thought 
to act by reducing the free-iron concentration far below that 
required for bacteria to grow thus inhibiting bacterial 
growth. However, it has also been reported to be a significant 
promoter of neutrophil adhesion. Therefore, it may also act by 
enhancing the localization of the neutrophils at the site of 
infection, thereby aiding the clearance of bacteria by 
recruited neutrophils (Qseas gt^  ai., 1981).
The increase in Oz consumption which occurs during leukocyte 
phagocytosis was first observed in 1333 by Baldridge and 
Gerard. This was later correlated with the production of toxic 
oxygen products in the ’’respiratory burst” . Changes which 
occur in neutrophils during the ’’respiratory burst” are shown 
in Table 2. The toxic oxygen species produced by phagocytes
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were reviewed by Badwey and Karnovsky (1980). The general 
microbicidal responses of phagocytes are summarised in Table
3.
Another important anti-bacterial property of neutrophils is 
the increased hydrogen ion concentration that is generated in 
the phagosome (Rous, 1925a, b ) . Estimates of the pH within 
phagosomes range from 3,0 to 6.0 depending on the species 
studied and the time of sampling (Jensen and Bainton, 1973; 
Mandell, 1970).
B . pertussis has been reported to live for a time as an 
intracellular parasite of macrophage (Gray and Cheers, 1967a). 
The bacterium appeared to survive intracellularly for periods 
of up to one month in murine macrophage, albeit at levels of 
less than 1% of the original numbers. However, no studies on 
whether B .pertussis could outlast the macrophage, multiply 
and possibly reinitiate infection have been reported. This 
B .pertussis intracellular phase was termed the "complaisant 
phase” and occurred also with Mucobacterium tuberculosis (Gray 
and Cheers, 19B7b) . Mucobacterium tuberculosis survives 
intracellularly by preventing phagosome-lysosome fusion (Goren 
êJL 1 1976) . The mechanism by which B . pertussis may 
survive in macrophage is unknown.
Inherited disorders of neutrophil microbicidal activity 
include myeloperoxidase deficiency (Lehrer e^ a_l. , 19B9) and 
chronic granulomatous disease (Holmes et, al^ . , 19B7) , the 
latter normally being fatal in the first decade of life. 
Neutrophils from chronic granulomatous disease patients lack a 
NADPH oxidase which, when activated, triggers the respiratory 
burst CBabior et al^ . , 1975; Curnutte et , 1975). Bacterial 
products which interfere with microbicidal activity of 
neutrophils include LPS (Weiss e^ , 1990; Henricks et aj . ,
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Microbicidal responses of phagocytes^
A. Degranulation CDz-independent)
1 . Cationic proteins
2. Proteases
3. Lactoferrin
4. Lysozyme
5. Acid hydrolases
6. Myeloperoxidase
B. Oxidative respiratory burst CGz-dependent)
1. Myeloperoxidase-associated
a. Hydrogen peroxide
b . Halogénation
c. Luminol-enhanced chemiluminescence
2. Superoxide, singlet oxygen, and other reactive 
oxygen radicals
^Modified from Quie C19B3).
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1903) and enzymes such as catalass (Mandell, 1975). _In vitro 
methods of measuring neutrophil microbicidal activity involve 
either direct (Quie , 1967) or indirect methods such as
nitrobluB tétrazolium reduction (Baehner at ai.- . 1976) or 
chemiluminescence (Allen at , 1972). Since a major portion 
of the work contained in this thesis involves the use of 
chemiluminescence a review of the technique is given in 2.2.6.
2.2.6. The use of chemiluminescence as an assau of 
mloxQj3it:ldal activitu
Chemiluminescence was first described by Allen et al .
(1972) who found that opsonized bacteria elicited a 
chemiluminescent response from human neutrophils upon 
phagocytosis. They correlated chemiluminescence with 
hexose-monophosphate shunt activity and suggested that 
chemiluminescence reflected the generation of singlet oxygen. 
Cheson et St. (1976) later found that superoxide dismutase 
and catalase both inhibited chemiluminescence and proposed 
that light production was due to reactions between ingested 
particles and some or all of the active oxidising agents 
produced during the neutrophil "respiratory burst". Allen and 
Loose (1976) described the use of the compound luminol 
(5-amino-2,3-dihydro-l,4-phthalazinedione) to enhance 
chemiluminescence. They demonstrated that when luminol was 
added to a rabbit macrophage suspension chemiluminescence was 
observed following phagocytosis of bacteria. Previously, in 
the absence of luminol no chemiluminescence had been detected 
The compound lucigenin (bis-N-methylacridinium nitrate) has 
also been used to amplify the chemiluminescent response 
produced by phagocytes (Allen, 1901). Luminol is oxidised by
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products of the myeloperoxidase system CDaChatelet gj^ , ,
1902; Dahlgren and Stendahl, 1963) whereas lucigenin-dependent 
chemiluminescence is almost entirely dependent upon superoxide 
production (Allen, 1981).
Hatch Bjt gi. (1978) used luminol-enhanced chemiluminescence 
to study the anti-bacterial activity of neutrophils stimulated 
by N-formyl-methionyl peptides. They found that there appeared 
to be a definite relationship between peptide structure and 
chemiluminescence activity, with fMLP being the most active 
peptide tested. Neutrophils stimulated by ffILP give a unique 
bimodal chemiluminescent response in the presence of luminol. 
The first peak is extracellular in origin while the second 
peak is cell-associated (Bender and Van Epps, 1903). In the 
presence of lucigenin, fMLP-stimulated neutrophils give only a 
single chemiluminescent peak which appears to be extracellular 
in origin (Dahlgren et_ gi.. , 1905).
Other studies using luminol-enhanced chemiluminescence have 
correlated neutrophil bactericidal ability directly with 
chemiluminescence production (Horan e_t aj^ . , 1902) . 
Chemiluminescence has also been used to evaluate the effect of 
serum opsonins on the anti-bacterial activity of phagocytes. 
(Easmon et al., 1900; Robinson al_. , 1904). Opsonization 
of microorganisms causes an increased chemiluminescent 
response and this can be used as a probe for the presence of 
specific antibodies against a certain organism (Welch, 1900). 
Lilius et gl_. (1905) reported that chemiluminescence can be 
be used to detect the presence of opsonins against 
B.pertussis: higher levels of opsonins against B.pertussis 
were found in whooping cough patients than in vaccinated 
controls. In addition, they reported that sera from 
unvaccinated infants contained no opsonins against
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B .pertussis.
Büockx (1984) reviewed the use of chemiluminescence as a 
tool for studying phagocyte function. Harder (1904) reviewed 
the use of bioluminescence, which mainly involves the use of 
firefly luciferase; an enzyme which reacts with ATP to give 
off light. The luminescence produced during the ATP-firefly 
luciferase reaction can be used to check for the presence of 
viable bacteria. This is useful as a probe for bacteraemia and 
bacteriuria, anti-microbial susceptibility testing, and 
antibiotic and vitamin assays.
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Part 3: Effect of B.pertussis components on ohanacutBs
2.3.1. Vaccine
A pertussis vaccine was reported to inhibit macrophage 
outpouring into a zone of thermal coagulation necrosis in the 
brains of experimental animals (Levine and Sowinski, 1372). In 
addition, pertussis vaccine was also reported to inhibit 
murine macrophage elongation, migration, and peritoneal 
cellular exudate formation (Benjamin at. Si.*, 1981). The 
component responsible for all activities was labile to heating 
at BO°C for 30 min.
2.3.2. Adanulate cuclase
Confer and Eaton (1982) found that extracts or culture 
supernates of B .pertussis containing high levels of 
heat-stable adenylate cyclase activity had a wide-range of 
anti-phagocyte activities. These included inhibition of 
superoxide production by human neutrophils and alveolar 
macrophages, a reduction of the direct bactericidal capacity 
of neutrophils, and inhibition of neutrophil chemotaxis and 
particle ingestion. Symes eJL al.. (1983) reported that 
B .pertussis adenylate cyclase suppressed the oxidative burst 
of human monocytes although it had no effect on phagocytosis. 
Confer e^ t gJL_. (1304) suggested that the adenylate cyclase 
entered the phagocytes and induced unregulated cyclic AMP 
formation which impaired cell function. Hewlett gt al_. (1985) 
observed the considerable similarity between the adenylate 
cyclase of B .pertussis and the oedema factor of Bacillus 
anthracis. which is also a heat-stable, calmodulin-dependent
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adenylate cyclase that inhibits neutrophil function CLeppla, 
1982; O'Brien gt aJL. , 1985). The oedema factor requires the 
Bacillus anthracis protective antigen before it can enter 
mammalian cells and induce an increase in cAMP. Leppla (1982) 
suggested that the protective antigen binds to mammalian cells 
and provides a receptor for the oedema factor. A similar 
receptor-mediated mode of entry may exist for the B.pertussis 
adenylate cyclase (Hewlett gt gJL.. , 1985) .
2.3.3. Pertussis toxin
The polymorphonuclear leukocyte-inhibitory factor (PIP) of 
B , pertussis was first described by Utsumi gt aj^ . (1378).
This factor inhibited the chemotactic and phagocytic capacity 
of neutrophils. In a later publication Imagawa gt al .
(1900) suggested that PIP may be identical to the 
lymphocytosis-promoting factor of B .pertussis. Granule 
enzyme secretion by rabbit neutrophils induced by the 
pro-inflammatory mediators ffILP, C5a, and leukotriene B4 was 
suppressed by purified PT (Becker et al. , 1985). PT also 
inhibited the rise in intracellular calcium concentrations 
induced by fMLP in both rabbit (flolski et al. , 1984) and 
guinea-pig neutrophils (Gkajima and Ui, 1304). Both fMLP- and 
leukotriene B4-induced increases in actin association with the 
cytoskeleton in rabbit neutrophils is also inhibited by 
PT-treatment (Shefcyk ejt gl. , 1985). The increase in the 
cytoskeletal actin produced by phorbol myristate acetate, on 
the other hand, was not affected by the toxin. PT has now 
become useful as a tool for the study of signal transduction 
during neutrophil activation by pro-inflammatory mediators 
(Becker et gl., 1906).
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PT inhibited murine macrophage migration and chemotaxis 
In vitro as well as altering their spreading capacity on 
tissue culture dishes (Meade at gl. , 1984). The toxin also 
inhibited the chemotaxis of human neutrophils tn vitro and 
partially inhibited neutrophil adherence to protein-coated 
plastic surfaces, most notably after augmentation of adherence 
with fMLP (Spangrude gL al. , 1985). Lad §1 gl. (1986) 
reported that PT does not influence phagocytosis by human 
neutrophils. Meade gt gl. (1984), however, have reported that 
PT inhibited Fc-mediated phagocytosis by murine macrophage. 
This discrepancy can perhaps be explained by differences 
between the cells and in the methods used to assay 
phagocytosis.
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OBJECT OF RESEARCH
Many successful pathogenic microorganisms have mechanisms 
for interfering with the anti-microbial activities of host 
phagocytes. However, the extent to which this generalization 
applies to Bardetella pertussis infection has only recently 
been considered. The aim of the present investigation was to 
assay the effects of B .pertussis components on phagocytes.
This study focused on neutrophils exclusively and explored the 
effect on neutrophil function of the following components of 
B .pertussis: PT, FHA, and LPS. The neutrophil functions of 
primary interest were adhesiveness and bactericidal response 
to a pro-inflammatory mediator CfMLP) and whole-cells of
B .pertussis. As the project developed it became apparent 
that the neutrophil response to fMLP had applications for 
monitoring the preparation of acellular pertussis vaccines.
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The strains used are listed in Table 4. The B .pertussis 
Tohama and 10334 strains were obtained from stock cultures 
kept at Dept, of Microbiology, Glasgow University, Glasgow, 
U.K. The other four strains were kindly supplied by Dr. A. A. 
Weiss (Department of Microbiology and Immunology, Box 678, 
Medical College of Virginia, Richmond, Virginia 23298-0001). 
Weiss eJi gl. (1903) have described the isolation of the 
avirulent mutants noted in Table 4.
A loopful of growth from a 72 h culture grown at 37*=*C on 
Bordet-Gengou medium (Gibco Biocult Diagnostics Ltd., Paisley, 
Scotland), containing 20% (v/v) sterile, defibrinated horse 
blood (Gibco), was used to inoculate each litre of 
Stainer-Scholte (99) medium modified such that the level of 
Tris present was 1.25 g 1“ ‘ (Stainer and Scholte, 1971). The 
organisms were either grown in shaken culture in X-mode 
(NaCl-containing) medium or in C-mode medium containing 
MgSO* instead of NaCl (Brownlie g l . , 1985). The 
intact bacteria used for the chemiluminescence and 
hydrophilicity assays were from 48 h shaken cultures grown at 
37°C. The bacteria were then stored frozen at -70°C in 
phosphate-buffered saline (PBS; section 8.1) containing 10% 
(v/v) glycerol until used.
4.2. Processing of bacterial culture supernates
Cultures of bacteria grown for 48 h at 37°C in modified 95 
medium were centrifuged at 6000 g for 30 min at 4^C. The 
supernates were then filtered through a glass fibre paper 
filter (Whatman) then a Millipore filter (0.45 pm pore size)
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A summary of the B .pertussis strains used in the 
chemiluminescence studies.
Organism Virulence factors absent*
B .pertussis 10334 NONE
B .pertussis Tohama NONE
B . pertussis 347 PT, AC, HLY, FHA, HLT
B . pertussis 340 AC, HLY
B . pertussis 353 FHA
B . pertussis 357 PTi
*Some cell-associated PT present.
(Weiss gt al , 1903)
^AC-adenylate cyclase, HLY-haemolysin,
FHA=Filamentcus haemagglutinin, HLT=heat-labile toxin
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to remove residual cells. Culture supernates were added to an 
Amicon DCS Hollow Fibre Dialyzer/Concentrator with a molecular 
mass cut-off of 1000kDal. The resulting filtrates were then 
re-filtered using a filter with a molecular mass cut-off of 100 
kDal and concentrated 15-30 fold.
4.3. Preparation of filamentous haemannlutinin
Filamentous haemagglutinin was kindly given by Dr. L. A. E. 
Ashworth (Public Health Laboratory Service, Centre of Applied 
Microbiology and Research, Porton Down, Salisbury, U.K.) and 
was stored at -20°C until use. It was diluted in 
HEPES-buffered saline (HBS) prior to use.
4.4. Preparation of 1ioopolusaccharide endotoxins
B . pertussis 165 (phase I) LPS was obtained from LIST 
Biological Laboratories Ltd (501-B Vandell Way, Campbell, 
California 35008, USA). Salmonella minnesota (smooth) and 
Salmonella minnesota Re5S5 (rough) LPS were obtained from 
Sigma. All were reconstituted according to manufacturer's 
instructions except that HBS was used in place of distilled 
water. Any further dilutions were also made in HBS.
4.5. Preparation of pertussis toxin
PT was obtained from two sources. One sample was obtained 
from LIST Biological Laboratories Ltd and was reconstituted in 
2 ml of sterile, distilled water and stored at 4*^ C until use. 
Further dilutions were made using HBS, The adenylate cyclase
activity of this preparation was less than 1.0
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picamalBs/min/|ig in the presence of 1.0 pfl calmodulin, 
according to the supplier. In addition, the lowest 
concentration of the toxin which caused haemagglutination of 
goose red blood cells was 195 ng ml"*, according to the 
supplier. The other PT preparation used was kindly donated by 
Dr. V . Y . Parera (Dept, of Microbiology, Glasgow University). 
This toxin preparation was purified using the method of Perera 
et al. (1985). Briefly, the toxin was isolated by 
Fetuln-Sepharose affinity chromatography of cytoplasmic 
fractions of cultures of B.pertussis 18334, phase I, grown for 
48 h at 37*=*C in cyclodextrin liquid medium (Imaizumi at al . . 
1903).
4.5. Pertussis vaccine preparation
An acellular pertussis vaccine was kindly supplied by Mr. M. 
Christodoulides (Dept, of Microbiology, Glasgow University). 
The vaccine, which consisted predominantly of PT and FHA, had 
been prepared from a culture supernate extract of S .pertussis 
77/10319 grown statically for 5 days at 37*=*C in 55 X-mode 
medium. The culture supernate extract had been detoxified by 
the carbodiimide-toxoiding technique of Christodoulides gt. 
al. , (1987).
4.7. Protein estimation
Protein content of samples were determined by the method of 
Herbert et al. (1971). Bovine serum albumin (B5A) was used as 
a standard.
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4.8. Treatment of samples for electrophoresis
Samples were adjusted to 100-200 pg of protein ml-*. Each 
sample (0.1 ml) was added to 0.1 ml of solubilising buffer 
(0.1 M Tris-HCl buffer, pH 6.0, containing 3% (w/v) sodium 
dodecyl sulphate (SOS), 5% (v/v) B-mercaptoethanol, 10%
(v/v) glycerol and 0.01% (w/v) of bromophenol blue) and the 
mixtures heated at 100°C for 5 min prior to loading on the 
gel.
4.0. Sodium dodecul sulphate poluacrulamide gel 
electrophoresis (SDS-PASE)
A modification of the method of Laemmli (1970) was used. 
Stacking gels contained 4.5% (w/v) acrylamide and 0.12% (w/v)
N ’N ’-methylenebisacrylamide (Bis). Separating gels contained 
15% (w/v) acrylamide and 0.4% (w/v) Bis. Both stacking and 
separating gels contained 0.2% (w/v) SDS.
Samples (10-30 pi) were layered directly onto the gels and 
electrophoresis was performed at 30 mA per gel until the 
dye-front reached the separating gel when the current was 
increased to 45 mA per gel. The gels were then stained either 
by the silver stain technique of Oakley et al_. (1900) or by 
the periodate LPS stain technique of Tsai and Frasch (1982).
For molecular mass determinations, some of the samples were
run side-by-side with marker proteins. These were bovine serum
albumin (BSA; molecular mass=B6 kDal), egg albumin (molecular
mass=45 kDal), glyceraldehyde-3-phosphate dehydrogenase
(molecular mass=36 kDal) carbonic anhydrase (molecular mass=29
kDal), trypsinogen (molecular mass=24 kDal), trypsin inhibitor
(molecular mass“2 0 .1 kDal) and alpha-lactalbumin (molecular
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mas3“14.2 kDal), all obtained from Sigma.
4.10. Heat-labile toxin assau
Samples CO.05 ml) containing 100-200 pg protein ml— % were 
injected subcutanaously into groups of 3-week old HaM/ICR 
female mice. Skin reactions were scored after 24 b by 
measuring the zone of haemorrhage at the site of injection 
CParton, 1906).
4.11. Haemagglutination assau
Defibrinated horse blood was obtained from Gibco. Fresh 
rabbit blood was collected in 3.8% Cw/v) sodium citrate. Both 
preparations were washed three times in normal saline. A wash 
comprised centrifugation at 400 g for 5 min with removal of 
the supernates between washes. After the final wash the 
erythrocyte pellets were resuspended to give a 0.5% Cv/v) 
suspension in normal saline. Aliquots (50 pi) of erythrocyte 
suspension were added and mixed to the contents of separate 
wells containing 50 pi of dilutions of test sample. All 
samples were tested in duplicate and the experiment was 
performed in round-bottomed Cooke microtitre plates. 
Haemagglutination was assayed after overnight incubation at 
4^C. The haemagglutinin titre was recorded as the reciprocal 
of the highest dilution giving complete haemagglutination.
4.12, Adenulate cuclase assau
The assay was performed as described by Brownlie et_ al. 
(1905) except that calmodulin (bovine brain; Sigma) was added
52
to the reaction mixture to give a final concentration of 0.3 
p M . Cyclic AMP was assayed by the cAMP-binding protein method 
of Tovey gt. gLi.. (1974) using a cyclic AMP assay kit 
CAmersham. Kit Code no. TRK.4B2). The assay could detect a 
minimum of 0.2 pmol cAMP per assay tube.
4.13. Enzume-linked, immunosorbent assau CELISA) for 
filamentous haemagglutinin
The monoclonal antibody preparations and reference 
filamentous haemagglutinin preparation used for this assay 
were kindly supplied by Dr. L. A. E. Ashworth (Public Health 
Laboratory Service, Centre of Applied Microbiology and 
Research, Salisbury, Porton Down, U.K.). Both the monoclonal 
and FHA preparations were isolated as described by Irons gt 
§1.. (1983). All incubations were dona in a humidified box.
Buffer recipes used are given in section 8.2. NUNC-immunoplate 
1-9GF ELISA plates were coated with 200 pi of a 1 pg ml~^ 
solution of the monoclonal antibody F2 in 0.05 M carbonate 
buffer, pH 9.6, and incubated overnight at 4°C. The plates 
were then washed with PBS containing 0.05% (v/v) Tween-20 
CPBST). Serial dilutions of the unknowns and standard FHA 
preparation were prepared in PBST and 200 pi of each dilution 
added to each consecutive well. All samples were assayed in 
duplicate. The plate was then incubated at 37*=*C for 2 h , 
washed with PBST, and 200 pi of monoclonal antibody F3-horse 
radish peroxidase conjugate (0.5 pg mi” *-) in PBST then added 
to each well. After a further incubation at 37°C for 2 h and 
subsequent washing of the plate in PBST, 200 pi of the 
substrate was added to each well. The substrate, HzOz and 
phenylenediamine, was prepared by the addition of 20 pi of a
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EG volumes solution of HzOa and 34 mg of O-phenylenediamine 
(Sigma) to 100 ml of citrate/phosphate buffer (pH 5.0). The 
plate was then incubated for 30 min in the dark at room 
temperature and the reaction stopped by the addition of 50 pi 
of 12.5% (v/v) HzSO*. The of each well was then
determined using a Titertek flultiskan MC photometer (Flow 
Laboratories). A graph of absorbance at 492 nm versus 
loSxoFHA cone (ng/well) was drawn and the FHA content of the 
unknowns calculated by comparison with the reference FHA 
preparation using a parallel line assay.
4.14. Hudrophilicitu assau
A modification of the method of Robinson gt gl. (1983) was 
used. The bacteria used were from frozen cultures as noted in 
section 4.1. After thawing, the bacteria were washed twice in 
PBS by centrifugation. Each wash comprised centrifugation at 
9,000 g for 60 sec. After washing the bacteria were 
resuspended in PBS and the Eooo set at 1.00. N-octane (300 pi) 
was then added to 4 ml of the bacterial suspension and the 
suspension mixed for 1 min. After standing for 20 min at room 
temperature the upper, hydrophobic layer was removed and the 
Eooo of the remaining aqueous layer determined. This value, 
after correction for a PBS control, was multiplied by 100 and 
expressed as the % Hydrophilicity of the organism.
4.15. Viable count of bacteria
A nalidixic acid-resistant B .pertussis Tohama strain 
(Minimum inhibitory concentration (MIC) of 60 pg nalidixic 
acid ml"*- of Bordet-Gengou medium) was kindly supplied by
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Dr C . J. Smith CDept. of Microbiology, Glasgow University). 
This organism was grown for 4B h on Bordet-Gengou medium at 
37*^C, harvested in sterile PBS and then plated onto fresh 
Bordet-Gengou medium for overnight incubation at 37°C. This 
overnight culture was harvested in HBS and washed twice by 
centrifugation at 9000 g for 30 sec. The bacterial suspension 
was then standardised so that it had an E^oo of 0.50.
Dilutions of the preparation made in sterile PBS were plated 
onto selective Bordet-Gengou plates containing 40 pg 
cephalexin ml” * (Sigma) and 30 pg nalidixic acid ml-i (Sigma). 
Duplicate plates were used for each dilution (0.1 ml) and the 
viable counts obtained from each plate after incubation for 5 
days at 37°C. The viable counts obtained were expressed as 
colony-forming units (C.F.U.) ml” *- of the original suspension.
4.16. Neutrophil preparation
Human peripheral blood from normal healthy volunteers was 
collected in heparin (10 units ml"*- of blood) and the 
neutrophils obtained after dextran sedimentation and density 
gradient centrifugation on Ficoll-Paque (Pharmacia) as 
described by Boyum (1968). Rabbit peripheral neutrophils were 
obtained by the method of Henson (1971). Briefly, rabbit 
peripheral blood was collected in acid citrate dextrose 
solution, centrifuged at 550 g for 20 min and the plasma and 
buffy coat layers discarded. Neutrophils were then isolated 
from the erythrocyte/neutrophil suspension by sedimentation of 
erythrocytes by addition of an equivalent volume of saline 
containing 2.5% (w/v) gelatin (Difco). Neutrophils were 
isolated from peripheral pig blood by the same technique 
except that saline containing 3% (w/v) gelatin was used. All
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peripheral neutrophil preparations were washed twice in HBS 
prior to use.
Rabbit peritoneal neutrophils were obtained from female New 
Zealand White albino rabbits. Briefly, 500ml of normal saline 
containing 0.1% Cw/v) oyster glycogen (Sigma) was injected 
intraperitoneally and the peritoneal exudate collected 4 h 
later (Lackie, 1977). The exudate was stored at 4“C and 
used within 2 days of isolation. Before use the cells were 
washed once in divalent-cation-free HBS-EDTA then in HBS. 
Contaminating erythrocytes were removed from all neutrophil 
preparations after the first wash, using hypotonic lysis. 
Washed cells were used within 2 h of preparation. To obtain a 
monodisperse population of cells for the aggregation and 
chemiluminescence assays the cells were passed through a 10 
pm Nitex filter CPlastok Associates, Birkenhead). Cell 
suspensions contained >95% neutrophils and cell viability was 
>95% as determined by Trypan Blue exclusion. Cell numbers were 
standardized by counting with a haemocytometer.
4.17. Aggregation assau
The method of Lackie (1977) was used. HBS was used for 
suspension of the neutrophils and as diluent in all 
aggregation experiments. Cell suspensions were placed in 
polystyrene vials (41x15 mm) to which appropriate samples were 
added, the final volume in each vial being 1 ml. The number of 
cells in each vial was approximately 10*^  ml” *-. Vials were 
shaken at 140 reciprocations min”*- in a water bath for 1 h at 
37°C. The total particle count was determined by removing an 
aliquot of 0.5 ml using a micropipette and a tip with an 
aperture enlarged to approximately 2 mm in diameter. This
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sample was then diluted in 10 ml of cold, filtered 0.9% Cw/v) 
NaCl solution containing 0.01% Cw/v) sodium azide and counted 
on a Model Zs Coulter Counter (Coulter Electronics Ltd. 
□unstable, Bedfordshire, England). The counter was fitted with 
a 200 pm aperture tube; the amplification” * setting was 0.5 
and the aperture current”* setting was 0.177. Only particles 
greater than 5 pm in diameter were therefore registered by the 
counter.
For convenience the results shown in tabular form were 
presented as the "Effect” CE) which was calculated as
E = 10. log: (count in control)
(count in experimental)
Thus inhibitors of aggregation will give a negative value of E 
and agents which increase aggregation will give a positive 
value. An E value of zero indicates no effect (Lackie, 1977). 
The results shown in the figures were presented as 
% Aggregation. This value was calculated as
% Aggregation (control count)”(experimental count)
(count in control)
X 100%
4.18. Chemiluminescence assau
This assay was performed using an automated luminometer 
(Ulallac LKB 1251 Luminometer) connected to a Acorn BBC 'B 
microcomputer. Chemiluminescence emission was measured in 
millivolts (mV) at 37°C. The number of neutrophils per assay 
tube was 10*^  and the final volume per tube was 700 pi. Luminol 
(Sigma) was added at the start of each assay by automatic
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dispenser to a final conc of 10“=* M . Luminol tuas first 
prepared as a 10“= M solution in dimethyl sulphoxide, 
diluted 100-fold in HBS, then stored at -20*=*C until use. The 
stimulus used was either the soluble synthetic peptide fMLP 
(Sigma) or suspensions of intact bacteria. The final 
concentration of fMLP per assay tube was 10“^ M . The bacterial 
stimulus was prepared from frozen (-70°C) suspensions as noted 
in section 4.1. The bacteria were washed twice in HBS and 
resuspended so that the bacterial suspension had an E^oo of 
0.50. Each wash comprised centrifugation at 9000 g for GO sec. 
This suspension (50 pi) was used as the intact bacterial 
stimulus. If fMLP was used as the stimulus then it was added 
by automatic dispenser in a luminol/fMLP mixture. In the 
chemiluminescence assays in which intact bacteria were used as 
the stimulus, the bacteria were added prior to automatic 
dispensing of luminol.
Before addition of a stimulus, the neutrophils were always 
pre-heated for 20 min at 37°C. If neutrophils were pre-treated 
with toxins or test agents the pre-incubation times were 
always lenghtened to 60 min unless otherwise specified. When 
either fMLP or intact bacteria were used as the stimulus, 
samples were usually assayed in triplicate or duplicate 
respectively and the chemiluminescence results shown are mean 
values. The count time per tube was varied according to the 
stimulus used: 0.5 sec for fMLP and 12 sec for the bacterial 
stimulus. Although shown as continuous traces, the 
chemiluminescence curves shown in the results section are 
actually derived from a finite number of observations. The 
frequency of sampling was varied for the different stimuli; 
approximately every 90 sec for fMLP and every 225 sec for the 
bacterial stimulus. The peak values and total
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chemiluminescencs counts of certain of the chemiluminescence 
results were tabulated for easier comparison and 
chemiluminescence curves are usually not shown for these 
results.
4.13. Statistical tests
The Student t-test as described in Campbell (1981) was used 
to evaluate the significance of differences between the two 
population means in various experiments. This test was used 
only if the data had been obtained by random sampling from a 
normal, or approximately normal, distribution and the 
variances of the two populations did not differ significantly 
when tested using the F-test. If the variances of the two 
groups differed significantly the Fisher— Behrens test was then 
used to evaluate any differences between the population means 
(Campbell, 1981). The degree of difference between the means 
of the control and experimental groups were either not 
significant (P>0.05), marked with no asterisk, or significant 
at the levels P<:0.05, Px<0.01, or P^O.OOl which was denoted 
with *, **, or *** respectively.
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RESULTS
Part 1: The influence of B.pertussis fractions and purified
components on neutrophil aggregation
5.1.1. Effect oF cutopiasmic and supernatant fractions
Preliminary investigations showed the presence of neutrophil 
aggregating activity in cytoplasmic fractions of B .pertussis 
(table 5). However, cytoplasmic fractions contain a relatively 
large number of different components and therefore B .pertussis 
culture supernates were prepared since they contain fewer 
components, which would make it easier to characterise any 
aggregating factors. Identification of the aggregating 
factor(s) was also made easier by the separation of 
B ■pertussis culture supernates into three fractions by 
pressure dialysis as follows: molecular mass > 1000 kDal (High 
molecular mass fraction), molecular mass <1000 kDal but > 100 
kDal (Medium molecular mass fraction), and molecular mass < 100 
kDal (Low molecular mass fraction). The Low molecular mass 
fraction had no detectable aggregating activity while both the 
other two fractions were more active than the cytoplasmic 
fraction, with the Medium molecular mass fraction being the 
most active (table 5) . The Medium molecular mass fraction was 
then used for further aggregation studies. The activity of 
both X-mode (virulent) and C-mode (avirulent) supernatant 
fractions were compared. The results indicated that the X-mode 
supernatant fraction had approximately Four times more 
aggregating activity than the corresponding C-mode fraction 
(figure 1). B .parapertussis culture supernates were also 
separated into three fractions, identical to the molecular 
mass ranges used for the B .pertussis culture supernates.
B. parapertussis X-mode Medium molecular mass fractions did
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Table 5
Influence of various crude B .pertussis X-mode fractions on 
the aggregation of rabbit peritoneal neutrophils.
Sample Cone
(ng/ml)
Mean effect* + SEM
Cytoplasmic 7680 +3.47*** + 0.33
fraction 1536 +0.81*** + 0.15
307 +0.10*** + 0.06
High molecular 6667 +4 . IB*** + 0.48
mass supernatant 2222 +2.27*** + 0.16
fraction 741 +0.78*** + 0.05
Medium molecular 1000 +5.IB*** + 0.39
mass supernatant 200 +4.93*** 0.32
fraction 40 +3.01*** + 0.19
Low molecular 6667 + 0.16 + 0 .18
mass supernatant 2222 -0.01 + 0.10
fraction 741 -0.10 + 0.06
(count in control)^Derived using Effect - lO.logio
(count in experimental)
A positive value for the effect indicates an enhancement 
of aggregation and a negative value indicates inhibition. 
***=P<0.001, **=P<0.01, *P=<0.05, otherwise not 
significantly different from control suspension (P>0.05).
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; n>4
Elaure 1 . The aggregation of rabbit peritoneal neutrophils by
B. x -  and c-mode and B . parapertussis X-mode
supernatant fractions. Each point shown is a mean and SEM of 0 
observations.
#  *= B . pertussis X-mode .
^  ” B .pertussis C-mode.
■  = B.parapertussis X-mode.
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not enhance aggregation (figure 1). In addition, neither of 
the other two (High molecular mass or Low molecular mass)
B .parapertussis supernatant fractions were active (table B ) .
A Medium molecular mass fraction from uninoculated 
Stainer-Scholte X-mode (SS-X) culture medium had no 
significant effect on neutrophil aggregation (table 7). This 
suggested that the component(s) responsible for aggregation 
was a bacterial product rather than some component of the 
medium. In addition, the neutrophils showed the expected 
response to known inhibitors, theophylline and caffeine 
(Lackie, 1974), and a known inducer of aggregation, fMLP 
(□’Flaherty et. aJL.. , 1977), indicating that the assay was 
capable of showing either inhibition or enhancement of 
aggregation (table 7). To confirm that the neutrophil 
aggregating activity observed in the B .pertussis supernatant 
fractions was not a general response to added protein, of any 
nature, BSA and fibronectin were assayed for their effects on 
neutrophil aggregation. These proteins were chosen since their 
molecular mass, BSA (GB kDal) and fibronectin (approximately 
400 kDal), approximated to the lower molecular mass (70 kDal 
for adenylate cyclase) and higher molecular mass (220 kDal for 
FHA) range of the protein-containing virulence factors 
produced by B .pertussis. Neither BSA nor fibronectin 
significantly influenced neutrophil aggregation at the doses 
tested (table 7).
The B . pertussis supernatant fractions were also assayed on 
rabbit peripheral blood neutrophils (table 8). The aggregation 
of the rabbit peripheral cells was enhanced by both X- and 
C-mode fractions with the X-mode fraction being the most 
active. The enhancement of aggregation of rabbit peripheral 
cells, by either X- or C-mode fraction, was not as marked and
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Table G
Influence of B .paraoertusslg X-mode supernatant fractions 
on the aggregation of rabbit peritoneal neutrophils.
Supernatant Cone Mean effect* + SEM
fraction* (ng/ml)
High 8000 “0.04 + 0.16
molecular 1600 +0.03 ±- 0.16
mass 320 -0.04 + 0.07
Medium 1600 +0.04 + 0 .03
molecular 320 +0.01 0.09
mass 64 +0.02 0,05
Low 8000 -0.15 + 0 .17
molecular 1600 -0.06 + 0 .12
mass 320 +0.01 + 0 . 12
‘Supernatant fractions derived as shown in 
section 4.2.
’‘■Derived as in table 5; n>4. No effect was 
significantly different from control suspension 
CP>0.05).
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lable. 7,
Influence of inhibitors, an inducer and other agents on the 
aggregation of rabbit peritoneal neutrophils.
Agent Cone Mean effect* + SEM
Theophylline 5.0 mM -0.45*** + 0.04
Caffeine 5.0 mM -0.50*** + 0.02
fMLP 2x10-* M +11.6*** + 0.30
BSA 12.0 pg ml-* -0.17 i. 0.06
4.0 pg ml-* “0.10 i. 0 .05
Fibronectin 3 .8 pg ml-* +0. IB 4- 0.03
0 .3 pg ml-* -0.11 + 0 .10
SS-X medium* 1 in 25 Cv/v) +0.03 + 0.08
‘A Medium molecular mass fraction, which had been 
concentrated 26-fold, obtained from uninoculated 
X-mode medium.
^Derived as in table 5; n>4.
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Tabla , SL
Influence of the B .pertussis X- and C-mode supernatant 
fractions* on the aggregation of peripheral neutrophils
Mode
Protein
cone
(ng/ml) Human
Mean effect 
Pig
* + SEM
Rabbit
2222 +0.03 + 0.18 -0.13 0.08 +0.79*** + 0.16
X 741 -0.01 + 0.04 -0 .05 + 0.09 +0.51** + 0.03
247 +0.07 0 .06 -0.09 + 0.07 +0.44** 4- 0 .05
2222 -0.03 + 0 .18 +0.02 0.07 +0.29** 4- 0.11
c 741 -0.04 + 0.21 -0.05 + 0 .07 +0.26* 4- 0.00
247 +0.03 + 0.17 -0.02 + 0.07 +0.17 4- 0.10
‘Medium molecular mass fractions. 
^Derived as in table 5; n>4.
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did not occur at such low dosas as with rabbit peritoneal 
neutrophils. When similar doses of either X- or C-mode 
fraction were assayed on human or pig peripheral blood 
neutrophils, no significant effects were found.
The data for the influence of the B.pertussis supernatant 
fractions on neutrophils from different species, although 
obtained using the same assay techniques, had been obtained at 
different times. Further measurements were then made using 
human peripheral and rabbit peritoneal neutrophils in the same 
experiment. The cells were placed in separate vials and the 
influence of the B .pertussis X-mode supernatant fraction on 
neutrophil aggregation was assayed. The results confirmed that 
the B .pertussis X-mode supernatant fraction enhanced the 
aggregation of rabbit peritoneal but not that of human 
peripheral neutrophils (table 3).
An additional experiment was performed to assay whether 
trace erythrocyte contamination of the peripheral neutrophil 
preparations was perhaps affecting neutrophil aggregation. 
Trace amounts of erythrocytes may have preferentially bound 
any active component(s) in the supernatant fractions and 
therefore have stopped binding of the active component(s) to 
the peripheral neutrophil preparations. This would perhaps 
have explained why the aggregation of human or pig peripheral 
neutrophils was not influenced by X- or C-mode B .pertussis 
supernatant fractions. Lysed human erythrocytes were added to 
the most responsive cells, rabbit peritoneal neutrophils, and 
the aggregation pattern compared with that of an 
erythrocyte-free preparation of the same neutrophil 
suspension. A study showed that the B .pertussis X-mode 
supernatant fraction caused aggregation of rabbit peritoneal 
neutrophils even in the presence of erythrocytes (table 10).
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lakls-a
The species-specificity of the neutrophil aggregating 
activity in the B .pertussis X-mode supernatant fraction*
Protein Mean effect* + SEM
cone
(ng/ml) Rabbit peritoneal Human peripheral
1000 +5.27* + 0 . 5 3 +0.05 + 0.05
ECO +4.04* + 0 . 3 3 +0.12 + 0.03
40 +1.35* + 0 . 0 5 +0.11 + 0 .03
^Medium molecular mass fraction. 
^Derived as in table 5; n-2.
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The influence of human erythrocyte contamination on the rabbit 
peritoneal neutrophil aggregating activity in the 
B.pertussis X-mode supernatant fraction*.
Protein Mean effect * + SEM
cone
(ng/ml) minus erythrocytes plus erythrocytes^
1000 +5.31* + 0.04 +5.88* + 0 . 2 4
200 +3.29* + 0.11 +3.84* + 0 . 3 2
40 +0.68 + 0 . 0 7 +0.85 + 0 . 0 2
‘Medium molecular mass fraction.
“Peripheral human blood erythrocytes had been obtained 
by dextran sedimentation after 30 min at 37°C. After two 
washes in MBS, 10 pi of the packed human erythrocyte 
pellet was lysed in 1 ml of distilled water, 25 ml of HBS 
was then added to the lysed cell suspension and 0.15 ml of 
this preparation was added to each vial.
^Derived as in table 5; n-2.
G3
These results (tables 9 and 10) appeared to confirm that the 
speciBs-specificity of the neutrophil aggregating activity in 
the supernatant fractions was not artefactual,
5.1.2. Influence of heating on supernatant fraction activltu
A known characteristic of PT is that it loses biological 
activity after heating at 0O°C for 30 min (Wardlaw and Parton, 
1903). No aggregation-promoting activity was found in the X- 
or C-mode B.pertussis supernatant fractions after such 
heat-treatment (table 11). This indicated that the 
component(s) responsible for aggregation was not heat-stable, 
thereby ruling out LPS, and that the neutrophil aggregating 
activity in the supernatant fractions may have been due to 
P T . The effect of similar heat-treatment on FHA activity is 
unknown (but see section 5.1.7.).
5.1.3. Enhancement bu pertussis toxin
To find whether the neutrophil aggregating activity detected 
in the B .pertussis supernatant fractions was due in part or 
full to PT or to some other component, purified PT (LIST 
Biological Laboratories Ltd) was assayed on various neutrophil 
types (table 12). Purified PT enhanced aggregation of all 
three neutrophil types tested, with rabbit peritoneal 
neutrophils being the most responsive. Unlike the 
B .pertussis supernatant fractions, PT enhanced aggregation 
of human peripheral neutrophils. PT was not assayed on pig 
peripheral neutrophils. The X- and C-mode B .pertussis 
supernatant fractions both enhanced the aggregation of rabbit 
peritoneal neutrophils at lower doses than P T . The differences
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Table,11
Influence of heat-treatment of the B.pertussis supernatant 
fractions* on the aggregation of rabbit peritoneal
neutrophils.
Protein 
Mode cone
(ng/ml)
Mean effect* + SEM
Unheated Heated:
1000 + 5 .16*** +1 0.39 +0.03 4- 0.12
X 200 +4.93*** + 0.32 -0.13 + 0.09
40 +3.01*** 0.19 -0.12 0 .08
1000 +4.82*** + 0.39 +0.03 + 0.13
c 200 +3.43*** + 0 .20 -0.16 t. 0.03
40 +1.56*** 0.40 -0.09 + 0.07
‘Medium molecular mass fractions.
“BO°C for 30 min.
*DerivBd as in table 5; n-B for unheated and 4 
for heated.
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lablfi IS.
Influence of purified pertussis toxin on neutrophil aggregation
Dose 
(ng/ml) Rabbit peritoneal*
Mean effect* + SEM 
Rabbit peripheral Human peripheral*
1000 +6.54*** + 0.32 +2.32*** +0. 0 8 +2.34*** + 0.33
200 +1.32** + 0.21 +0.15* + 0.02 +0.51 + 0.15
40 +0 .20 + 0.08 +0.18* + 0 . 0 3 +0 .26 + 0.08
^Derived as in table 5; n=4 or *B observations.
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observed between the aggregating activities of PT and the 
supernatant fractions suggested that other factors may be 
involved in influencing the aggregation patterns obtained with 
the supernatant fractions. A dose-responss curve (figure 2) 
was obtained using PT prepared by the method of Perera et a l . 
(1985). This toxin sample appeared to have similar aggregating 
activity to the preparation from LIST Biological Laboratories 
Ltd (table 12). The PT preparation of Perera ak al- (1985) 
was used for all further studies involving this toxin.
5.1.4. Biological, enzumic and SDS-PAGE analysis of 
supernatant fractions
In an attempt to identify which component of B .pertussis was 
responsible for the rabbit neutrophil aggregating activity in 
the supernatant fractions, the fractions were examined for the 
presence of known biologically-active components of 
B .pertussis. The heat-labile toxin of B .pertussis can be 
assayed by its ability to induce a haemorrhagic response in 
mouse skin. Parton (1986) reported that a dose of 1.2 pg of 
crude heat-labile toxin (B .pertussis cytoplasmic fraction) 
caused a 17-20 mm haemorrhagic zone when injected 
subcutaneously into 3-5 week old mice. Graded doses 
(containing 5-10 pg protein) of the supernatant fractions were 
injected subcutaneously into groups of mice but no zones of 
reaction were observed after 24 h , indicating that no 
detectable heat-labile toxin was present.
The B .pertussis supernatant fractions were examined for the 
presence of haemagglutinating activity since both PT and FHA 
are haemagglutlnins (Irons and MacLennan, 1979). No detectable 
agglutination of horse or rabbit erythrocytes was found in
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Figure g . The influence of pertussis toxin on the aggregation 
of rabbit peritoneal neutrophils. Each point shown is a mean 
and SEM of 5 observations.
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either the B .pertussis X- or C-mode supernatant fraction at 
the doses tested Cup to 5 pg protein per well). These 
erythrocyte species are not the most sensitive for assaying 
B .pertussis haemagglutinins (Irons and MacLennan, 1379). 
Borringe e;t al.. C130B) reported that the haemagglutinating 
activity of FHA is lost when FHA is incubated under shaken 
conditions. The B .pertussis supernate fractions used were 
isolated from a shaken culture and any FHA present may have 
lost, or have reduced, haemagglutinating activity. Although 
active PT might have been present, low levels may not have 
been detected using horse or rabbit erythrocytes. A more 
sensitive assay for PT would have been a PT ELISA. An FHA 
ELISA of the B .pertussis supernatant fractions was done and 
the results are shown in section 5.1.9.
The adenylate cyclase of B .pertussis can be measured in an 
enzymic assay which involves two steps: incubation of the 
sample with ATP, the substrate from which the adenylate 
cyclase generates cAMP, and then measurement of the cAMP 
generated by a competitive binding assay involving 
radiolabelled cAMP (section H.IE.). The cAMP assay used would 
detect 0.2 pmol per assay tube. Using this assay, no 
detectable adenylate cyclase activity was found in doses (5 pg 
protein per assay tube) of B .pertussis supernatant fraction 
(table 13). However, a low level of adenylate cyclase activity 
was detected in the more concentrated B .parapertussis 
supernatant fraction (14 pg protein per assay tube).
The B .pertussis supernatant fractions were also examined 
using SDS-PAGE to assay whether any of the bands correlated 
with the known molecular mass of any of the B.pertussis 
virulence factors. SDS-PAGE of the samples (containing 1.5 pg 
protein) showed mainly the presence of low molecular mass,
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Adenylate cyclase activity of the supernatant fractions*
Supernatant Protein
conc
fraction (pg/tube)
Cyclic AMP* 
produced 
(pmol cAMP min-*)
Adenylate cyclase 
(pmol cAMP min” * 
mg protein-*)
B.oertussis 5 
(X-mode)
none detected -
p. Pertussis. 5 
(C-mode)
none detected -
B .Daraoertussls 14 
(X-mode)
4 EBB
*riBdium molecular mass fractions.
^Standard curve shown in section 0.4. (figure 13).
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diffuse bands which were of similar molecular mass to purified 
B.pertussis LPS and stained using a LPS-spacific stain 
(plate ID. These bands were resistant to protease suggesting 
that the bands were non-proteinaceous in nature (plate 2D. 
Coomassie blue stain of the gels was not done since there was 
not enough protein present in the samples to be detected by 
this staining method.
5.1.5. Effect of LPS from B.oertussis and other bacteria
B .pertussis- LPS had been detected in those B .pertussis 
supernatant fractions which contained potent neutrophil 
aggregating activity. A visual comparison of SDS-PAGE patterns 
(plate ID indicated that the probable levels of LPS in the X- 
or C-mode B .pertussis supernatant fraction loaded onto the gel 
was less than the concentration of the purified reference 
B.pertussis LPS i .m, less than 1.5 pg LPS. Since the 
samples of supernatant fractions loaded onto the gels 
contained 1.5 pg protein, and the protein dose-range of the 
supernatant fractions which contained active neutrophil 
aggregating activity had previously been determined (figure 
ID, the approximate concentrations of LPS over this active 
dose-range could be calculated. The highest degree of 
neutrophil aggregation observed with a supernatant fraction 
occurred with a dose of 1.0 pg protein ml~* and therefore 
doses of LPS around the figure of 1.0 pg LPS ml-* were 
assayed. No significant enhancement of the aggregation of 
rabbit peritoneal neutrophils was found using purified 
B .pertussis LPS over the range tested (table 14). (The 
limulus amoebocyte lysate assay (Sigma Chemical Company, 1973) 
would have given a more exact estimation of the LPS
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Plate 1 . SDS-PAGE of B .pertussis Medium molecular mass 
supernatant fractions. The final concentration of each 
component loaded per well was: 1.5 pg protein of the 
B .pertussis X- or C-mode supernatant fraction, and
1.5 pg of B .pertussis LPS. The gel was stained using the 
periodate LPS staining technique of Tsai and Frasch C13BS)
1 = C-mode supernatant fraction.
2 = X-mode supernatant fraction.
3 - B . pertussis LPS.
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Plate g . Effect of protease-treatment on the SDS-PAGE profiles 
of the B .pertussis Medium molecular mass supernatant 
fractions. B .pertussis X- and C-mode supernatant fractions 
samples (containing 10 pg protein) and 10 pg B .pertussis LPS 
were treated with 1 pg of proteolytic enzyme (protease 
(type VII) or<<-chymotrypsin (type VII); Sigma) for 30 min at 
25°C. Solubilizing buffer was then added to each sample and 
the mixtures heated at 100°C for 5 min prior to loading on the 
gel. The final concentration of each component loaded per well 
was: 1.5 pg protein of the X- and C-mode supernatant fraction,
1.5 pg of B .pertussis LPS, and 0.15 pg of protease or 
c^-chymotrypsin. The gel was stained using the silver stain 
technique of Oakley et. al,. (1S0O) .
1 = Molecular mass standards.
2 = Protease.
3 = ^-chymotrypsin.
4 = B .pertussis LPS and protease.
5 = B .pertussis LPS and^-chymotrypsin.
6 = B .pertussis LPS.
7 = Molecular mass standards.
0 = C-mode supernatant fraction and protease.
3 “ C-mode supernatant fraction and<^cchymotrypsin.
10 = C-mode supernatant fraction.
11 “ X-mode supernatant fraction and protease.
12 = X-mode supernatant fraction and«^-chymotrypsin.
13 *= X-mode supernatant fraction.
14 “ B .pertussis LPS.
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Molecular 
mass (kDal)
66 0 ^  
45 0 ^  
36 0 —  
29-0 —  
24 0 "  
20 1 —  
14 -2
|. " D
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Influence of different types of LPS on the aggregation of
rabbit peritoneal neutrophils.
Dose Mean effect* + SEM, with LPS from
Cpg/ml) B .Dertussis S.Minnesota ReSSS S .Minnesota
10.0 -0.01 + O.IB -0.01 + 0 .24 -0.01 + 0 .04
1 .0 +0.05 + 0.18 +0.18 + 0 . 1 3 -0.13 + 0 . 0 6
0 .1 +0.00 + 0.07 +0.20 +0. 1 2 -0.11 + 0.01
^Derived as in table 5; n>4. No effect was significantly 
different from control suspension CP>0.05).
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concentration of the B .pertussis supernatant fractions.)
A characteristic of smooth LPS is that it produces a 
laddering effect, with multiple bands, on SDS-PAGE (Tsai and 
Frasch, 1982). The results indicated that B .pertussis LPS is a 
a rough LPS, since no laddering effect was observed after 
SDS-PAGE (plates 1 and 2). To assess whether a smooth LPS may 
influence the aggregation of rabbit peritoneal neutrophils 
smooth LPS from Salmonella minnesota was assayed. This was 
compared with the rough LPS of Salmonella Minnesota ReSSS and 
the rough LPS of B .pertussis. No LPS had any significant 
effect over the range tested (table 14). Doses of LPS over 10 
pg diminished neutrophil viability.
5.1.6. Influence of filamentous haemapglutinin
FHA is a potent haemagglutinin, especially active against 
goose erythrocytes, although erythrocytes from other species 
are also agglutinated. The effect of this haemagglutinating 
factor on neutrophil aggregation was investigated. FHA 
enhanced the aggregation of rabbit peritoneal neutrophils and 
appeared to be the most active bacterial component tested 
(table 15), FHA also enhanced the aggregation of rabbit 
peripheral neutrophils though the effect was not as marked and 
did not occur at such low doses as with rabbit peritoneal 
cells. Human peripheral neutrophil aggregation was not 
influenced by FHA. The effect of FHA on the aggregation of pig 
peripheral neutrophils was not investigated. There appears to 
be a similarity between the neutrophil aggregating activity of 
both purified FHA and the B .pertussis supernatant fractions 
since both enhanced the aggregation of rabbit but not human 
neutrophils. A dose-response curve of FHA-enhancement of
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Table 15
Influence of purified FHA on neutrophil aggregation
Dose Mean effect* + SEfI
Cng/ml) Rabbit peritoneal Rabbit peripheral Human peripheral
344 +5.80*** + 0.32 + 1 .33** + 0.28 +0.14 + 0 . 3 7
115 +4.82*** + 0.31 +0.52** + 0.14 -0.15 + 0 . 2 4
38 +4.22*** + 0 . 1 8 -0.07 + 0 . 1 5 -0.24 + 0.11
^Derived as in table 5; n“4 .
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aggregation of rabbit peritoneal neutrophils was obtained 
(Figure 3). These results suggested that FHA may be the major 
neutrophil aggregating factor present in the B.pertussis 
supernatant fractions.
5.1.7. Effect of heating on aooreoatina activity of 
fUamg.n.to.gg b9^ m#aülullnln
Heat-treatment (80°8 for 30 min) had destroyed the 
neutrophil aggregating activity present in the B.pertussis 
supernatant fractions (table 11). If FHA was the major 
neutrophil aggregating factor present in the supernatant 
fractions then similar heat-treatment should destroy the 
neutrophil aggregating activity of FHA. The neutrophil 
aggregating activity of FHA was indeed destroyed by such 
heat-treatment (table IB). This again suggested that FHA may 
have been the active neutrophil aggregating factor present in 
the B .pertussis supernatant fractions.
5.1.8. Enzumic. immunological and SDS-PAGE analusis of 
pertussis toxin preparations
The results had so far suggested that FHA and possibly PT
were both capable of enhancing neutrophil aggregation, with
FHA being the most active. Although PT appeared to have a
different species-specificity from FHA, it was possible that
minor contaminants of the PT preparations used were
contributing to the neutrophil aggregation patterns obtained
for the toxin. The PT preparations of both LIST Biological
Laboratories Ltd and that obtained by the method of Perera
et al. (1885) were therefore analysed for contamination by
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Figure 3 . The influence of purified FHA on the aggregation of 
rabbit peritoneal neutrophils. Each point shown is a mean and 
SEFI of 4 observations.
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Influence of heat-treatment of FHA on its aggregating 
activity for rabbit peritoneal neutrophils.
Dose Mean effect* + SEM
Cng/ml) Unheated Heated!
344 +5.80*** + 0 . 3 2 +0.14 + 0.11
115 +4.82*** + 0.31 +0 . OB + 0.14
30 +4.22*** + 0.18 -0 .03 + 0.12
for 30 min.
^Derived as in table 5; n“4 .
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other B .pertussis products.
No detectable adenylate cyclase activity (i.e. < 0.2 
pmol/min/pg protein) was found in a sample C13 pg per assay 
tube) of the PT preparation of Perera gt. aJL. (1985). A 
representative standard curve is shown in section 8.4. (figure 
19). The adenylate cyclase activity of the LIST Biological 
Laboratories Ltd preparation was reported to contain less than 
1.0 pmol/min/pg of toxin by the manufacturer.
The LIST Biological Laboratories Ltd preparation was assayed 
in an FHA ELISA. No detectable levels of FHA were found (table 
17). The FHA ELISA could detect a minimum of between 3-5 ng 
FHA per well. The PT preparation of Perera at a 4 . (1985) was 
not analysed by FHA ELISA due to an insufficient concentration 
of toxin.
Examination of both PT preparations by SDS-PAGE showed the 
expected pattern of five subunits (Tamura gt. al_. , 1982) . 
However, a contaminating band was also observed in both 
preparations (plate 3). An additional three contaminating 
bands were observed in the toxin preparation of Perera et al. 
(1985). SDS-PAGE of FHA shows multiple polypeptides, ranging 
from molecular mass 58,000 to 220,000 kDal (Irons et al .
1383), and it is possible that some of the contaminating bands 
observed in the PT preparations were actually FHA fragments. 
The low molecular mass, diffuse band observed only in the 
toxin preparation of Perera et gl_. (1985) has been 
confirmed as being LPS, which comprised about 4% (w/w) of this 
PT preparation (Dr. V . Y . Perera: personal communication).
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Tgtils.,.1.7.
An FHA ELISA of the supernatant fractions! and the pertussis 
toxin preparation supplied by LIST Biological Laboratories Ltd
Sample
Protein 
cone 
(ng/well)
A^?z
FHA* 
cone 
(ng/well)
B.Dertussis X-mode 2212 0 .023 < 3
supernatant fraction H O B 0.025 < 3
B.Dertussis C-mode 2225 0.034 < 3
supernatant fraction 1112 0.030 < 3
B.parapertussis X-mode 5571 0.025 < 3
supernatant fraction 2788 0.030 < 3
Purified PT 2500 0.026 < 3
preparation (LIST) 1250 0.02B < 3
!Medium molecular mass fractions.
^Standard curve shown in section 0.4. (figure 20)
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Plate 3 . SDS-PAGE of the different pertussis toxin 
preparations. The plate was supplied by Dr. V . Y . Perera 
CDept. of Microbiology, Glasgow University). The source of the 
toxin sample is shown in brackets. The gel was comprised of a 
discontinuous gradient of 13.5-20 % Acrylamide. The 
solubilizing buffer contained 4 M urea. The gel was stained 
using the silver stain technique of Oakley et a%. (1580). The 
contaminating bands, possibly FHA fragments, are labelled "a". 
The LPS band present in the toxin preparation of Dr. V . Y . 
Perera is labelled with a ”b ” .
1 = 1.0 pg pertussis toxin (LIST Biological Laboratories Ltd).
2 = 2.0 pg pertussis toxin (LIST Biological Laboratories Ltd).
3 = 1.0 pg pertussis toxin (Dr. V . Y . Perera).
4 = 2.0 pg pertussis toxin (Dr. V . Y . Perera).
5 “ Molecular mass standards.
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Toxin
subunit
1 —  
2 —  
3 —
Molecular
masslkPal)
-66 0
450 
36 0
29 0
240 
20 1
4
5
— b
14 2
5.1.9. Immunological analysis oF the B.pertussis supernatant 
Frag-t.igns
Studies had indicated that the neutrophil aggregating factor 
present in the B.pertussis supernatant fractions was possibly 
FHA. However, the B .pertussis culture supernate fractions used 
had been isolated from shaken cultures, in the absence of 
cyclodextrin, and would be expected to contain little, if any, 
FHA activity CArai and Munoz, 1979). An FHA ELISA of both the 
X- and C-mode supernatant fractions found no detectable FHA 
(table 17). The FHA ELISA used could detect a minimum of 3-5 
ng FHA per well. A possible explanation of this apparent 
contradiction is discussed in section 5.1.1.
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Part 2 : The influence of purified bacterial components on
rabbit peritoneal neutrophil chemiluminescence
5.2.1. Enhancement bu filamentous haemapolutinin and LPS
FHA enhances rabbit peritoneal neutrophil aggregation 
(figure 3); since enhancement of aggregation is often 
associated with metabolic effects, the influence of FHA on the 
chemiluminescent response of rabbit peritoneal neutrophils was 
assayed. B .pertussis LPS had no influence on neutrophil 
aggregation (table 14) and was assayed to determine whether 
any correlation could be made between the ability of a 
bacterial component to influence neutrophil aggregation and 
chemiluminescence. Both FHA and LPS induced neutrophil 
chemiluminescencB directly (table 10). A longer count time 
gave higher chemiluminescence counts, as expected, and was 
more sensitive in detecting any differences between the 
experimental and control mixtures. The smooth LPS of 
Salmonella minnesota and the rough LPS of Salmonella Minnesota 
Re595 were also assayed for their effects on neutrophil 
chemiluminescence. The LPS of Salmonella minnesota Re595 
induced higher levels of neutrophil chemiluminescence than 
either the rough LPS of B .pertussis or the smooth LPS of 
Salmonella minnesota at the 0.5 sec count time. The LPS of 
Salmonella minnesota Re595 was the roughest LPS assayed and 
there may be a correlation between degree of roughness of an 
LPS and its ability to stimulate neutrophil chemiluminescence 
directly. The results suggested that bacterial components 
which induce neutrophil chemiluminescence do not necessarily 
also influence neutrophil aggregation.
The chemiluminescence counts obtained at each individual
SO
Table 18
Direct stimulation of rabbit peritoneal neutrophil 
chemiluminescence by various purified bacterial products.
Count Test agent mU chemiluminescence + SEMi
time cone per
(sec) vial Experimental Control
0.5= 50 ng FHA 20.61** + 0.28 18.34 + 0.16
1 pg B .pertussis LPS 25.65** + 1.32 13.02 + 0.67
1 pg S .minnesota smooth LPS 23.61** + 1.00 13.02 + 0.67
1 pg S .Minnesota Re535 LPS 61,73*** + 1.03 13.02 + 0.67
12.0= 50 ng FHA 285.75*** + 13.28 170.50 + 4 . 5 6
1 pg B .pertussis LPS 472.67*** + 23.02 242.00 + 1 4 . 5
!Individual chemiluminescence counts were summed over the total 
assay time and the mean value obtained for each sample.
Cn>4 observations). For experimental values: ***=P.$0.001,
**=P^0.01, otherwise not significantly different from control value 
CP>0.05).
^The assay was done for 30 min with each vial being counted
approximately every 30 sec.
=The assay was done for 60 min with each vial being counted
approximately every 225 sec.
31
sampling time wars not much higher than background levels. A 
more sensitive technique of assaying the influence of 
bacterial components on neutrophil chemiluminescence is to 
assay the effects of the components on neutrophils stimulated 
by a different, more active stimulus. Both fMLP and intact 
bacteria stimulate a strong, characteristic chemiluminescence 
response when incubated with neutrophils. (Bender and Van 
Epps, 1903; Horan et. , 1982). The effects of purified 
bacterial components and B .pertussis fractions on the 
chemiluminescent response of rabbit peritoneal neutrophils 
induced by either fMLP or intact B .pertussis were therefore 
studied. The results are shown in Part 3 and Part 4 of the 
Results section.
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Part 3: The influence of purified bacterial components and
B.pertussis fractions on the chemiluminescent response 
of rabbit peritoneal neutrophils to fMLP
5.3.1. Effect of B.pertussis supernatant fractions
The B ■pertussis X- and C-mode Medium molecular mass 
supernatant fractions, used for the aggregation studies, were 
also assayed for their influence on the chemiluminescent 
response of rabbit peritoneal neutrophils to the 
pro-inflammatory mediator fMLP. The neutrophils were 
pre-incubated in the presence of the fraction before addition 
of the stimulus and the light-enhancing reagent luminol. 
FMLP-induced stimulation of neutrophils causes a bimodal 
chemiluminescent response in the presence of luminol. The 
first peak is extracellular in origin while the second peak is 
cell-associated (Bender and Van Epps, 1983). A typical bimodal 
chemiluminescent response of rabbit peritoneal neutrophils 
induced by fMLP is shown in figure 4. To simplify the 
presentation of the chemiluminescence results, the individual 
points were Joined and the chemiluminescence curves given as 
shown are continuous traces through the points and without the 
SEM bars.
A B .pertussis X-mode supernatant fraction enhanced 
chemiluminescence (figure 5) . The enhancing effect was 
observed even after pre-incubation for 15 min (figure 5, curve 
c) and longer pre-incubation times led to increased 
enhancement. Maximal enhancement appeared to occur after 
pre-incubation for approximately 60 min (figure 5, curve a). A 
longer pre-incubation period of 90 min gave no further 
enhancement (data not shown) . The peak values (highest count
93
Figure 4 . Neutrophil chemiluminescent response to fMLP. 
Rabbit peritoneal neutrophils were pre-incubated for BO min 
before addition of the stimulus. Each point shown is a mean 
and SEM of 3 observations. The data used was from figure 10
(curve d ).
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Figure 5 . The influence of pre-incubation time on the effect 
of a B .pertussis X-mode supernatant fraction on fMLP-induced 
chemiluminescence of neutrophils. Rabbit peritoneal 
neutrophils were pre-incubated in the presence of of the 
supernatant fraction (containing 2100 ng protein per vial) for
various times before addition of the stimulus. Supernatant
fraction was not added to the control. The figure shown is 
representative of 2 separate experiments.
a = GO min.
b = 30 min.
c = 15 min.
d = Control (buffer).
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over the time of assay) and total chemiluminescence counts of 
the data shown in figure 5 were tabulated and there was a 
positive correlation between chemiluminescence peak value and 
the total chemiluminescence produced (table 19).
An uninoculated culture medium fraction, as used in table 7, 
was assayed to determine its effect on the chemiluminescent 
response of rabbit peritoneal neutrophils to fMLP. This was 
done to assess whether some component of the medium was 
perhaps responsible for the enhancement of the neutrophil 
chemiluminescent response to fMLP shown in figure 5. The 1 in 
50 and 1 in 100 dilutions caused a slight enhancement of the 
peak values but did not effect the overall chemiluminescence 
produced (table 20). The 1 in 10 dilution had no significant 
effect on either the peak chemiluminescence value or on the 
overall chemiluminescence produced. In comparison, the 
B ■pertussis X-mode supernatant fraction dramatically enhanced 
both the chemiluminescence peak value and total 
chemiluminescence produced (table 19). An approximately 
equivalent concentration of the culture medium fraction had no 
effect confirming that a component produced by B .pertussis. 
and not some component of the medium, was responsible for the 
effects noted. A B .pertussis C-mode supernatant fraction also 
enhanced neutrophil chemiluminescence (table 21). At both 
doses tested the B .pertussis X-mode supernatant fraction 
induced significantly higher chemiluminescence peak values 
(P<0.01) and total chemiluminescence production (P<0.001) than 
similar doses of the C-mode supernatant fraction.
5.3.2. Enhancement bu filamentous haemaoalutinin
FHA induced the chemiluminescence of rabbit peritoneal
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Tab! s 19.
The influence of pre-incubation time on the effect of a 
B.pertussis X-mode supernatant fraction^ on fMLP-induced 
chemiluminescence of neutrophils: peak values and total
chemiluminescence.
Sample Pre-incubation mU chemiluminescence + SEM+
time (min) Peak value Total
Buffer 30 70.77 4- 7.01 722.50 + 29 . 13
Supernatant 15 1B7.53** + 9.31 009.20* + 44 .04
Supernatant 30 E7H.17*** -f B. 10 1130.62** 4" 66.91
Supernatant GO 364 .53*** + 32.91 1336.57*** 4- IB .28
*-The Medium molecular mass supernatant fraction;
dose=E100 ng protein per vial . 
fpeak value was the highest chemiluminescence value 
observed over 30 min while total chemiluminescence was the 
sum of the individual chemiluminescence counts over 30 min. 
Values given are a mean of 3 observations. For experimental 
values: ***=p^o.ooi, **=P^0.01, or *=P^0.05, otherwise not 
significantly different from control value CP>0.05).
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Table 20
The influence of uninoculated culture medium^ on
fMLP-induced chemiluminescence of neutrophils
Sample Dilution mV chemiluminescence + SEM+
Peak value Total
Buffer - 24.40 0.77 346.92 + 35 ,56
Medium 1 in 10 24.75 + 0.49 267.62 + 11 .88
Medium 1 in 50 27.21* + 0.64 337.30 i 30.61
Medium 1 in 100 27.84* 4* 1 .26 354.28 4- 36 . 16
Medium molecular mass fraction which had been 
concentrated 26-fold.
^Derived as in table 19; n*G.
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Table 21
The influence of B .pertussis X- and C-mode supernatant
fractions* on fMLP-induced chemiluminescence of neutrophils
Sample Protein cone mU chemiluminescence + SEM*
Cng/vial) Peak value Total
Buff er - 55.72 + 4.69 555.76 4- 37.11
C-mode 420 123,26*** + 5.67 778 .19*** 4- 40.58
2100 213.41** 4- 11.51 981.36*** 4- 23.52
X-mode 420 248.82** 4- 18.94 1187.53*** 4- 76 . 26
2100 321.67** 4- 25.07 1301.35*** 4- 32.21
^Medium molecular mass fractions. 
^Derived as in table 13; n-G.
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neutrophils directly (table IB), therefore FHA was assayed on 
the chemiluminescent response of these cells to fMLP. FHA 
enhanced neutrophil chemiluminescence at the relatively low 
doses of 10-50 ng (figure B ) . A dose of 250 ng (figure 6, 
curve a) had approximately the same enhancing effect as a dose 
of 50 ng (figure 6, curve b) for about the first 10 min, 
although a slight inhibitory effect was observed with the 250 
ng dose after about 20 min. A study of the response with time 
(figure 7) indicated that maximal enhancement occurred after a 
pre-incubation time of about BO min. An enhancing effect was 
first observed after a pre-incubation time of about 15 min. 
These results implicated FHA as the factor in the 
B .pertussis supernatant fractions responsible for the 
enhancement of the neutrophil chemiluminescent response to 
fMLP (section 5.3.1.).
To determine whether the enhancement of the neutrophil 
chemiluminescent response to fMLP by FHA was non-specifically 
caused by the addition of extracellular protein, 100 ng BSA 
(molecular mass=GG kDal) and 100 ng fibronectin (molecular
mass approximately 400 kDal) were assayed for their effect on
the neutrophil chemiluminescent response to fMLP (table 22).
Of the different proteins tested, only FHA had any significant 
influence on the neutrophil chemiluminescent response. Thus, 
FHA-enhancement of the neutrophil chemiluminescent response to
fMLP appears to be due to the specific structure of FHA,
rather than the fact that it is was simply a protein.
Although, a dose of 50 ng FHA had a slight stimulatory effect 
even in the absence of fMLP (table IB), this stimulation is 
not enough to account for the FHA-enhancement of neutrophil 
chemiluminescence in the presence of fMLP. Thus, the 
enhancement of neutrophil chemiluminescent response to fMLP by
100
Figure B . The effect of purified FHA on fflLP-induced 
chemiluminescence of neutrophils. Rabbit peritoneal 
neutrophils were pre-incubated in the presence of various 
doses of FHA for 60 min before addition of the stimulus. No 
FHA was added to the control. The figure shown is 
representative of 3 separate experiments,
a = 250 n g . 
b = 50 n g . 
c = 10 ng.
d = Control (buffer).
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.. The effect of pre-incubation time on the influence 
of purified FHA on neutrophil chemiluminescent response to 
friLP. Rabbit peritoneal neutrophils were pre-incubated in the 
presence of 50 ng FHA per vial for various times before 
addition of the stimulus. No FHA was added to the control. The 
individual chemiluminescence counts were summed over 30 min 
and expressed as % Chemiluminescence compared to the control. 
The control was given a value of 100%. Each point shown is a 
mean and SEN of G observations.
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Table 22
The effect of various proteins on neutrophil chemiluminescent
response to fMLP.
Sample Cone per mU chemiluminescence + SEM?
vial (ng) Peak value Total
Buffer - 46.3S ± 6 . 6 3  420.00 ±25.90
FHA SO 173.42*** ± 11.66 803.34*** ± 4 . 3 6
BSA 100 41.05 ± 3 . 6 4  303.71 ±42.95
Fibronectin 100 43.35 ± 7 . 2 7  367.36 ±20.66
Derived as in table 13; n=6.
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FHA appears to be a synergistic effect of the two agents.
5.3.3. Enhancement bu B.pertussis LPS
LPS appeared to be a major component of the B .pertussis X- 
and C-mode supernatant fractions (plates 1 and 2). Since 
B . pertussis LPS may have influenced the chemiluminescence 
results obtained for the supernatant fractions LPS was 
therefore assayed for its possible effects on neutrophil 
chemiluminescence (figure 8). B .pertussis LPS enhanced 
neutrophil chemiluminescence at doses as low as 1 pg (figure 
0, curve b) with maximal enhancement occurring with a dose of 
10 pg (figure 8, curve a). A 0.1 pg dose of LPS had no 
significant effect on the neutrophil chemiluminescent response 
to fMLP (figure 8, curve c ) . Although increased neutrophil 
chemiluminescence was obtained with doses of LPS exceeding 10 
pg, neutrophil viability was diminished by such treatment.
B . pertussis LPS required a pre-incubation time of about 15 
min before any enhancement effect was observed (figure 8). 
Maximal enhancement occurred with a pre-incubation time of 
about 60 min. The results (table 21) indicated that doses of 
the B .pertussis supernatant fractions, down to 420 ng protein 
per vial, significantly enhanced neutrophil chemiluminescence. 
Using the same calculations as in 5.1.5., the levels of LPS 
likely to be present in the lowest dose of the B .pertussis 
supernatant fractions assayed (420 ng protein per vial) would 
be less than - 420 ng LPS per vial. LPS enhanced
neutrophil chemiluminescence only at doses of about 1000 ng 
and above. This indicated that some factor, other than LPS, 
was responsible for enhancement of the neutrophil 
chemiluminescent response to fMLP observed with the X -  or
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Finure B . The influence of B .pertussis LPS on fMLP-induced 
chemiluminescence of neutrophils. Rabbit peritoneal 
neutrophils were pre-incubated in the presence of various 
doses of LPS for 60 min before addition of the stimulus. No 
LPS was added to the control. The figure shown is 
representative of S separate experiments.
a = 10 pg LPS. 
b = 1 pg LPS. 
c = 0.1 pg LPS 
d = Control (buffer).
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Figure 9 . The effect of pre-incubation time on the influence 
of B ■pertussis LPS on fMLF-induced chemiluminescence of 
neutrophils. Rabbit peritoneal neutrophils were pre-incubated 
in the presence of 10 pg LPS per vial for various times 
before addition of the stimulus. No LPS was added to the 
control. The individual chemiluminescence counts were summed 
over 30 min and expressed as % Chemiluminescence relative to 
the control. The control was given a value of 100%, Each point 
shown is a mean and SEM of B observations.
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C-mada B .pertussis supernatant fraction. In addition, the 
C-mode supernatant fraction contained slightly more LPS, as 
Judged from SDS-PAGE (plate 1), than the X-mode supernatant 
fraction but was not as active at enhancing the neutrophil 
chemiluminescent response to fMLP. This also suggests that 
some other factor, possibly FHA, was the dominant factor 
responsible for the enhancement of the neutrophil 
chemiluminescent response to fMLP noted with the B . pertussis 
X- or C-mode supernatant fraction. Although B .pertussis LPS 
caused a slight enhancement of neutrophil chemiluminescence, 
even in the absence of fMLP (table 18), this stimulation was 
not enough to account for B .pertussis LPS-enhancement of 
neutrophil chemiluminescent response seen in the presence of 
fMLP. Thus, like FHA, LPS-enhancement of neutrophil 
chemiluminescent response to fMLP appears to be due to a 
synergistic effect of the two agents.
5.3.1. A comparison of B.pertussis LPS with LPS from 
Salmonella Minnesota
B . pertussis LPS (rough) was compared to the LPS from 
Salmonella Minnesota (smooth) and Salmonella Minnesota 
Re585 (rough) to find whether B .pertussis LPS enhancement of 
the neutrophil chemiluminescent response to fMLP was specific 
to B .pertussis LPS, or typical of LPS in general (table S3). 
Salmpneila Minnesota ReSSS (rough) LPS was the most active,
B .pertussis LPS the second most active, while Salmonella 
Minnesota (smooth) LPS was the least active enhancer of 
neutrophil chemiluminescence. The higher dose (10 pg) of 
Salmonella Minnesota (smooth) LPS was not as active as the 
lower dose (1 pg), suggesting that neutrophil responsiveness
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Table 23
A comparison of the influence of B .pertussis and Salmonella 
Minnesota LPS on fflLP-induced chemiluminescence of neutrophils
Sample Cone per mV chemiluminescence + SEM*
vial (pg) Peak value Total
Buffer - 26.35 4- 2.62 346.62 4- 11 . 17
B.oertussis LPS 1 3 0 .36*** 4- 13 .20 667.34*** 4- 21 . 84
10 151.00*** 4- 4.37 362 .81** 4- 33.23
S.Minnesota ReSSS 1 132.32*** 4- 2.38 847.31*** 4- 21 .65
LPS (rough) 10 176.01*** 4- 6.07 312.23** 4- 23 . 33
S.Minnesota LPS 1 74.36** 4- 10 . 12 578.55*** + 21 .36
(smooth) 10 50.86*** 4- 3. 13 361.86 4- 25 . 37
^Derived as in table 13; n“B .
1ÛB
was diminished by treatment with the higher but not the lower 
dose. Thus, the effect of B .pertussis LPS on fMLP-induced 
chemiluminescence of neutrophils was not unique to that LPS.
All three LPS types stimulated neutrophil chemiluminescence in 
the absence of fMLP (table 18). This stimulatory effect may 
have contributed to LPS-enhancement of the neutrophil 
chemiluminescent response observed in the presence of fMLP 
(table 23). There was a correlation between degree of stimulus 
by LPS in the absence of fMLP and enhancement of 
chemiluminescence by LPS in its presence. For example, 
Salmonella Minnesota ReSSS (rough) LPS induced the highest 
levels of chemiluminescence both in the absence and presence 
of fMLP.
5.3-5. Inhibition bu pertussis toxin
PT inhibits rabbit peritoneal neutrophil secretory responses 
and chemotaxis induced by fMLP (Becker ejt ai.. , 1385) . The
effect of PT on fMLP-induced chemiluminescence of rabbit 
peritoneal neutrophils was investigated. The PT preparation of 
Perera e^ al_. (1365) was inhibitory (figure 10), and the 
degree of inhibition increased with dose of toxin: 6.4 ng 
caused a slight suppression (figure 10, curve c) with 160 ng 
causing almost complete suppression of chemiluminescence 
(figure 10, curve a ) . Pre-incubation of the neutrophils for 15 
min in the presence of the toxin had no significant effect 
(P>0.0S) on total chemiluminescence production (figure ll(i)). 
Significant inhibition of chemiluminescence (P<0.01) was first 
observed after a pre-incubation time of 30 min with maximal 
suppression occurring after a pre-incubation time of 60 min. 
The results suggest that 50% inhibition of total
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Figure 10. The inhibitory effect of pertussis toxin on 
fMLP-induced chemiluminescence of neutrophils. Rabbit 
peritoneal neutrophils were pre-incubated in the presence of 
various doses of the toxin for 60 min before addition of the 
stimulus. No toxin was added to the control. The figure shown 
is representative of 7 separate experiments.
a = 160 n g . 
b = 32 n g . 
c = 6.4 ng. 
d = Control (buffer) .
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Figure 11. The influence of pre-incubation time on the effect 
of pertussis toxin on neutrophil chemiluminescent response to 
fMLP. Rabbit peritoneal neutrophils were pre-incubated for 
various times in the presence of ISO ng of toxin per vial 
before addition of the stimulus. No toxin was added to the 
control.
Ci) Total measured chemiluminescence.
The individual chemiluminescence counts were summed over 30 
min and expressed as % Chemiluminescence relative to the 
control. The control was given a value of 100%. Each point 
shown is a mean and SEM of 6 observations.
Cii) A chemiluminescence curve.
The figure shown is representative of 2 separate experiments
a = 60 min 
b = 45 min 
c = 30 min
d = Control (buffer).
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chemiluminescence would occur if the neutrophils were 
pre-incubated in the presence of 150 ng of toxin for about 
35-40 min. Analysis of a chemiluminescence curve suggested 
that there was a lag period of between 30-40 min before any 
inhibitory effects of PT was evident (figure llCii)).
Earlier studies indicated that the PT preparation of Perera 
at al. (1985) was contaminated by trace amounts of other 
components; LPS and possibly FHA (section 5.1.0). Both FHA and PT 
activity are heat-labile whereas LPS activity is heat-stable. 
About 1 pg of B .pertussis LPS is required to enhance 
the fMLP-induced chemiluminescent response of rabbit 
peritoneal neutrophils significantly (figure 0). Levels of LPS 
as high as this were unlikely to be present in the relatively 
small amounts of PT used in the present chemiluminescence 
studies (6.4-lBO ng per vial). However, to verify that LPS was 
not modulating the inhibitory effect of PT, a PT preparation 
was heat-treated at 0O“C for 30 min to destroy PT activity but 
leave any LPS activity intact. The inhibitory effect of PT was 
partially abolished by heating for 10 min and completely 
destroyed by heating for 30 min (table 24). No enhancement of 
chemiluminescence was observed with the PT which had been 
heat-treated at 80*^C for 30 min confirming that there was 
insufficient LPS present to influence the results obtained.
5.3.6. Agents which elevate neutrophil intracellular cAMP
It has been well documented that cAMP and agents which 
elevate intracellular cAMP levels diminish both degranulation 
and other cellular responses of neutrophils (Cox and 
Karnovsky, 1973; Weissman et, aJL. , 1372). As a control
l i e
Table 24
The effect of heating on the inhibitory activity of pertussis 
toxin on fMLP-induced chemiluminescence of neutrophils.
Sample Cone per mU chemiluminescence ^  SEM*
vial Cng) Peak value Total
Buffer - 31 .21 + 3.74 234.45 + 11 .63
Toxin Cunheated) IBO 2.97** + 0.92 27.71** + 3.49
Toxin CBO°C for 10 min) ISO 22.59 + 3.31 122.34*** + 17 .71
Toxin (80=C for 30 min) IBO 25.90 + 2.37 219.97 + 9 .09
^Derived as in table IS; n-B.
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experiment, neutrophils were pre-incubated in the presence of 
various agents (caffeine, theophylline, and dibutyryl cAflP) 
known to increase intracellular cAMP levels. As might have 
been expected, the fMLP-induced chemiluminescent response of 
rabbit peritoneal neutrophils was inhibited by all three 
agents tested (table 25).
5.3.7. Influence of a pertussis toxin and filamentous 
haemaaolutlnin mixture
FHA enhanced the fMLP-induced chemiluminescent response of 
rabbit peritoneal neutrophils to fMLP (section 5.3.2.) whereas 
PT inhibited it (section 5.3.5.). Since both factors are 
secreted during bacterial growth, it was of interest to 
determine which effect would predominate. After pre-incubation 
with equal doses (50 ng) of both factors, the suppressive 
effect of PT overrode the enhancing effect of FHA. 
Pre-incubation of the neutrophils with 50 ng FHA and a higher 
dose of PT (ISO ng) caused a further reduction in 
chemiluminescence (table 26).
5.3.8. Influence of a pertussis toxin and B.oertussis LPS 
mixture
B . pertussis LPS enhanced the neutrophil chemiluminescent 
response to fMLP (section 5.3.3.) whereas PT inhibited it 
(section 5.3.5.). Rabbit peritoneal neutrophils were 
pre-incubated in the presence of a PT and B .pertussis LPS 
mixture to find which effect would predominate. Using a 
maximum enhancing dose of LPS (10 pg) and a maximum 
inhibitory dose of PT (160 ng) the inhibitory activity of PT
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Table S5
The effects of agents which elevate intracellular cAMP 
levels on fMLP-induced chemiluminescence of neutrophils
Sample Cone per mV chemiluminescence + SEM r
vial CmM) Peak value Total
Buffer - 123.25 + 4.88 681.58 + 8.27
Caffeine 5.0 2.31** + 0.08 35.30** + 1.02
Theophylline 5.0 3.48** + 0.18 50.61** + 1 .82
Dibutyryl cAMP 0.2 51.48** + 1.28 275.42** + 4.56
^Derived as in table 13 ; n=7.
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Tabl e
The influence of a mixture of pertussis toxin and FHA on
fMLF-induced chemiluminescence of neutrophils.
PT cone FHA cone mU chemiluminescence + SEM*
per vial per vial Peak value Total
zero zero 16 .67 + 0.45 250.32 4- 3.52
50 ng zero 6.71* + 1 .60 82.72*** 4- 22.90
160 ng zero 3.26** 4- 0 .78 40.14** 4- 8.65
zero 50 ng 117.00** + 16.10 867.97** 4- 73.03
50 ng 50 ng 14 .09 + 3.74 141.60* + 42 .00
160 ng 50 ng 6.00*** 4- 1 .25 65.35*** 4- 12.40
*Derived as in table 19; n”9
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almost completely suppressed the enhancing effect of LPS 
(table 27).
5.3.3. Monitoring of a toxoidina procedure
An acellular pertussis vaccine, which was a culture 
supernate extract consisting predominantly of PT and FHA, was 
assayed for its effects on neutrophil chemiluminescent 
response to fMLP (table 28). An untoxoided vaccine preparation 
inhibited, whereas a toxoided vaccine preparation enhanced, 
neutrophil chemiluminescent response to fMLP. The enhancement 
of neutrophil chemiluminescent response to fMLP by the 
toxoided vaccine sample was abolished by heat-treatment of the 
vaccine at 0O°C for 30 min. This suggests that the factor(s) 
responsible for enhancement of chemiluminescence was not 
heat-stable, thereby ruling out LPS. It also indicated that 
the enhancement of chemiluminescence observed with the 
unheated vaccine sample was not caused non-specifically by the 
addition of extracellular protein. Since PT inhibits 
fMLP-induced chemiluminescence of neutrophils (figure 10), 
this indicated that the toxoiding procedure used had abolished 
most, if not all, of the PT inhibitory activity present in the 
untoxoided vaccine preparation. This correlated with 
observations that the toxoiding procedure used had abolished 
the leukocytosis-promoting and histamine-sensitizing activity 
of the untoxoided vaccine preparation (Mr. M. Christodoulides : 
personal communication).
The enhancement of neutrophil chemiluminescence observed 
with the pertussis vaccine (table 20) may have been due to 
FHA. A toxoided FHA preparation (kindly supplied by Mr. M. 
Christodouiides, Dept, of Microbiology, University of Glasgow)
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Table 27
The influence of a mixture of pertussis toxin and 
B ■pertussis LPS on fMLP-induced chemiluminescence of
neutrophils.
PT cone LPS cone mV chemiluminescence + SEM*
per vial per vial Peak value Total
zero 
150 ng 
zero 
160 ng
zero 20.21 + 1.23
zero 1.43** + 0.02
10 pg 107.55** + 2 . 3 3  
10 pg 5.14*** + 0.18
232.78 + 16.13
13.87** + 0.20
838.42*** + 13.87 
51.34*** + 1.53
*Derived as in table 13; n-6.
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Table 28
The effect of an acelluiar pertussis vaccine on
friLP-induced chemiluminescence of neutrophils.
Sample Protein cone mU chemiluminescence + SEM +
per vial Cpg) Peak value Total
Buffer - 22.03 + 2 . 8 5 198.11 + 14.18
Untoxoided vaccine 0.1 3.89** + 1.07 28.12** + 2.43
Toxoided vaccine 10.0 52.00** + 1 . 1 4 354.62** + 4.87
1 .0 34.58** + 1 . 4 3 290.27* + 28.37
Toxoided vaccine*- 1.0 24.43 + 1.99 219.72 + 25.93
"•Heated at BO“C for 30 min. 
^Derived as in table 19; n“B
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was assayed for its effects an neutrophil chemiluminescence 
(table 29). This FHA preparation had been toxoided using the 
same procedure as the one applied to the B .pertussis culture 
supernate extract. A 50 ng dose of toxoided FHA caused a 
slight enhancement of neutrophil chemiluminescence, however, 
the degree of enhancement of both peak value and total 
chemiluminescence was not as great as that induced by a 
similar dose of untoxoided FHA CP<0.001). The peak neutrophil 
chemiluminescence value induced by a dose of 2500 ng toxoided 
FHA was not significantly different from that induced by a 
dose of 50 ng untoxoided FHA CP>0.05). However, the untoxoided 
preparation induced a greater level of total neutrophil 
chemiluminescence (P<0.01) than neutrophils treated with the 
highest dose of toxoided FHA. The results suggest that the 
enhancement of chemiluminescence observed with the toxoided 
vaccine was probably due to residual FHA activity. Thus, the 
toxoiding procedure used reduces the biological activity, as 
assayed using chemiluminescence, of both PT and FHA.
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IgblG. .ga
The effect of a toxoided FHA preparation on fMLP-induced
chemiluminescence of neutrophils.
Sample Dose per mV chemiluminescence + SEM+
vial (ng) Peak value Total
Buffer - 14.83 + 1 .04 232.03 + 11 .70
Untoxoided FHA 50 45.41** + 4.00 458.50*** + 7 .53
Toxoided FHA 50 21.04* 1 .33 287.26** + 8.84
250 40.56*** ^ 1 .47 343.58*** + 21 .32
2500 45.40** + 4.53 377.38*** + 22.38
"■Derived as in table 13; n=B.
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Part 4: The chemiluminescsnt response of rabbit peritoneal 
neutrophils to different strains and mutants oF 
Bordetella pertussis
5.4.1. Effect of antigenic modulation
Chemiluminescence studies using whole-cells of B .pertussis 
as a stimulus were performed to assess the effects of 
B .pertussis virulence factors on the response of rabbit 
peritoneal neutrophils to intact bacteria. A noticeable 
difference between the chemiluminescence patterns obtained 
when using either fhLP or an intact bacterial stimulus is that 
fMLP induces a bimodal response (figure 4) whereas intact 
bacteria induce only a single peak (figure 12). The first, 
rapid chemiluminescence peak seen after neutrophil stimulation 
by fMLP is an extracellular peak (Bender and Van Epps, 1303). 
This rapid peak is absent from the slower chemiluminescent 
response induced by whole-cells of bacteria.
During antigenic modulation, B .pertussis loses a wide range 
of virulence-associated factors and undergoes changes in outer 
membrane proteins (section 2.1.5). Two B.pertussis strains. 
10334 and Tohama, were assayed for differences in 
chemiluminescence patterns to find whether antigenic 
modulation significantly influenced the ability of these 
bacteria to avoid killing by neutrophils. The
chemiluminescence peaks took up to 2 h for the full rise and 
subsequent decline to background levels although the 
chemiluminescence peak values occurred within the first 60 min 
of assaying. The X-mode organisms induced chemiluminescence 
patterns with peak values at about 30-40 min which declined to 
background levels at about 75 min. The C-mode organisms
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Figure 12. Neutrophil chemiluminescent response to intact 
X-mode B .pertussis Tohama. Rabbit peritoneal neutrophils 
were pre-incubated for 60 min before addition of the stimulus. 
Each point shown is a mean and SEN of 2 observations. The data 
used was from figure 16 (curve d ) .
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induced chemiluminescence patterns with peak values between 
40-50 min which persisted for about a Further 40 min before 
declining to background chemiluminescence levels. Since the 
First 60 min oF the chemiluminescence peaks induced by intact 
B .pertussis gave the most interesting information, most 
experiments were run For 60 min only and all data shown here 
is From this period only. To simplify the chemiluminescence 
results individual time points were linked and the 
chemiluminescence curves shown are continuous traces through 
individual time points and without the SEM bars.
B . pertussis Tohama and 1B334 C-mode organisms induced 
significantly lower chemiluminescence peaks and total levels 
of chemiluminescence than their respective X-mode counterparts 
(Figure 13). A transposon-induced mutant, B .pertussis 347 
grown in X-mode culture medium (Figure 13, curve c), induced a 
similar chemiluminescence pattern to the C-mode organisms 
(Figure 13, curves b and d ) . The B .pertussis Tohama X-mode 
strain (figure 13, curve F ) induced a significantly higher 
chemiluminescent peak and total chemiluminescence than the 
B .pertussis 18334 X-mode strain (Figure 13, curve e ) . The 
susceptibility of an organism to phagocytosis decreases as its 
hydrophilicity increases (Standahl, 1883). A lower rate of 
phagocytosis would correspond with a lower rate of 
intracellular, but perhaps not extracellular, bacterial 
killing. B . pertussis 347 and the B . pertussis C-mode organisms 
were significantly more hydrophilic (P<0.001) compared to the 
B . pertussis X-mode organisms (Figure 15(i)). Thus there was a 
positive correlation between the chemiluminescence levels 
generated and the hydrophobicity of the organisms.
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Figure 13. Effect of B .pertussis antigenic modulation on the 
induction of neutrophil chemiluminescence. The bacteria were 
grown in either X- or C-mode S3 medium in shaken culture; the 
mode of the organism is given in brackets. Rabbit peritoneal 
neutrophils were pre-incubated at 37^C for 20 min before 
addition of the stimulus. The figure shown is a mean of 4 
observations and is representative of 8 separate experiments.
a = No stimulus, 
b = 18334 C O  . 
c = 347 CX). 
d = Tohama C O  . 
e = 18334 CX). 
f = Tohama CX).
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5.4.E. Studu of mutants
A study of the effect of individual components on neutrophil 
chemiluminescence generation to intact B .pertussis was done 
using transposon-induced mutants deficient in one or more 
virulence factors (table 4). The mutants were derived from a 
B .pertussis Tohama X-mode parental strain so this strain was 
included as a reference (figure 14). B .pertussis Tohama 
X-mode induced the highest chemiluminescence peak value and 
the highest level of total chemiluminescence (figure 14, curve 
f) which were significantly different from all other strains 
tested (P<0.05). The total amount of chemiluminescence and the 
chemiluminescence peak values produced by the adenylate 
cyclase- and haemolysin-deficient strain B . pertussis 348 
(figure 14, curve e), the FHA-deficient strain B .pertussis 353 
(figure 14, curve c), and the PT-deficient strain B .pertussis 
357 (figure 14, curve d) were not significantly different 
(P>0.05). The virulence factor-deficient strain B .pertussis 
347 (figure 14, curve b) induced the lowest chemiluminescence 
peak value. It also induced the lowest levels of total 
chemiluminescence over the time tested and was the only strain 
to differ significantly (P<0.001) in its degree of 
hydrophilicity when compared to the other mutants or parental 
strain (figure 15(ii)). The extreme hydrophilicity of 
B .pertussis 347 may explain the ability of the organism to 
stimulate a low level of neutrophil chemiluminescence only.
5.4.3. Effect of pertussis toxin on neutrophil
chemiluminescent response _to whole-icsl 15 of B. pertussis
PT (160 ng) almost completely suppressed the neutrophil
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Figure 14. A study of neutrophil chemiluminescence generation 
against mutants of B .pertussis. The mutants were grown in 
X-mode SS medium in shaken culture. Rabbit peritoneal 
neutrophils were pre-incubated at 37°C for 20 min before
f
addition of the stimulus. The figure shown is a mean of 4 
observations and is representative of 8 separate experiments.
a “ No stimulus, 
b = 347 CX) . 
c = 353 CX) . 
d = 357 CX) . 
e = 348 CX). 
f = Tohama CX) .
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Figure 15. A correlation of whole-cell B .pertussis 
chemiluminescence pattern with bacterial hydrophilicity.
Cl) Antigenically-modulated strains.
(A) The individual chemiluminescence counts obtained For 
each B .pertussis strain over GO min were summed. The 
mean total chemiluminescence count was then plotted. 
Conditions were as For Figure 11. Cn=8 observations) 
CB) Hydrophilicity oF the diFFerent B .pertussis strains. 
Cn=8 observations).
Cii) B .pertussis mutants grown in X-mode.
(A) The individual chemiluminescence counts obtained For 
each B .pertussis strain over 60 min were summed. The 
mean total chemiluminescence count was then plotted. 
Conditions were as For Figure IE. Cn=8 observations) 
CB) Hydrophilicity oF the diFFerent B .pertussis mutants. 
Cn=B observations).
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chemiluminsscent response to fMLP (Figure 10), but a similar 
dose of the toxin caused only a slight inhibition (P<0.05), 
about 30%, oF the peak value and total chemiluminescence 
induced by intact B .pertussis (Figure IB, curve b ) . The lower 
dose oF PT (6.4 ng) caused a slight inhibition oF the peak 
value (P<0,05) but had no signiFicant eFFect (P>0.05) on total 
chemiluminescence production (Figure IB, curve c ) . The sample 
oF toxin used almost completely inhibited the neutrophil 
chemiluminescent response to FMLP, conFirming that the slight 
inhibitory eFFect oF PT on neutrophil chemiluminescent 
response to the intact bacteria was genuine, and not due to a 
loss in activity oF the toxin (data not shown). This suggested 
that although PT inhibited the neutrophil chemiluminescent 
response to FMLP and to intact B .pertussis. the response oF 
neutrophils to FMLP was more inhibited than the response to 
intact B .pertussis .
5.4.4. EFFect oF Filamentous haemapolutinin on neutrophil 
chemiluminescent response to intact B.pertussis
FHA stimulated neutrophil chemiluminescence directly 
(section 5.2.1.) and enhanced neutrophil chemiluminescent 
response to FMLP (section 5.3.2.) so FHA was assayed For its 
eFFects on the chemiluminescence oF neutrophils stimulated by 
whole-cells oF B .pertussis. FHA induced a greater rate oF 
neutrophil chemiluminescence production while the peak value 
and total chemiluminescence production were slightly reduced 
(P<0.05) by treatment with a dose of 50 ng of FHA (Figure 17, 
curve b ) . The decrease in peak value and total 
chemiluminescence observed aFter pre-treatment oF the 
neutrophils with FHA may have been arteFactual. Since
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Figure IB. The effect of pertussis toxin on neutrophil 
chemiluminescent response to intact X-mode B .pertussis Tohama 
Rabbit peritoneal neutrophils were pre-incubated in the 
presence of various doses of the toxin for 60 min before 
addition of the stimulus. No toxin was added to the control. 
The figure shown is representative of S separate experiments.
a = No stimulus, 
b = 160 n g . 
c = 6.4 n g . 
d = Control (buffer).
130
400
^  300
OJ
w
c
(X)
w
i/)
OJ
5 200
E
ZD
E
<u
j=
W
100
30 600
Time (min)
Figure 17. The effect of purified FHA on neutrophil 
chemiluminescent response to intact X-mode B .pertussis Tohama. 
Rabbit peritoneal neutrophils were pre-incubated in the 
presence of various doses of FHA for BO min before addition of 
the stimulus. No toxin was added to the control. The figure 
shown is representative of 0 separate experiments.
a = No stimulus. 
b = 50 ng. 
c = 10 ng.
d = Control (buffer).
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neutrophil pre-incubation with FHA induced a Faster rate of 
chemiluminescence production, the sampling regime used in 
which each sample was counted approximately every 225 sec, may 
miss the chemiluminescence peak values of the FHA-treated 
neutrophils. Also this may explain the apparent depression in 
total chemiluminescence measured. A reduction in the time 
between counting of each sample may have indicated whether the 
decrease in chemiluminescence peak value and total 
chemiluminescence of FHA-treated neutrophils was artefactual. 
Neutrophil chemiluminescence was enhanced significantly by FHA 
even in the absence of any other stimulus (table 18). This may 
have contributed to the chemiluminescent pattern obtained in 
the presence of FHA and whole-cells of B .pertussis.
5.H.5. Effect of a mixture of pertussis toxin and filamentous 
haemaoolutinin on neutrophil chemiluminescent response 
to whole-cells of B.pertussis
A mixture of PT and FHA (50 ng dose of each) was assayed to 
see which factor, if any, would predominate in modulating 
neutrophil chemiluminescent response to intact B .pertussis 
(table 30). The chemiluminescence peak value and total 
chemiluminescence produced by neutrophils was slightly 
decreased after pre-incubation with either PT or FHA alone. 
Pre-incubation of neutrophils with a mixture of both PT and 
FHA reduced both chemiluminescence peak value and total 
chemiluminescence produced. Neutrophils pre-incubated with 
both PT and FHA had a similar rate of chemiluminescence 
production as neutrophils pre-treated with FHA alone (data not 
shown). The results (table 30) showed that the 
chemiluminescence peak value and total chemiluminescence
132
lab is,
The influence of a mixture of pertussis toxin and FHA on
neutrophil chemiluminescent response to X-mode B .pertussis
Tohama.
PT cone FHA cone mV chemiluminescence + SEM*
per vial per vial Peak value Total
zero zero 332.83 + 14.40 4338.00 + 154.37
50 ng zero 276.34* + 13.50 3654.43** ±. 185.71
zero 50 ng 231.78* 4- 7 .43 3851.14* + 32.68
50 ng 50 ng 240.37*** + 3.30 3084.85*** + 103.74
^Derived as in table IS except values were obtained over 
BO min; n=S.
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produced by the PT and FHA-treated neutrophils was, however, 
significantly reduced compared to the FHA-treated neutrophils 
CP<0.001). The effects of a mixture of both PT and FHA on the 
neutrophil chemiluminescent response to intact B .pertussis 
were approximately similar to the cumulative effects of PT and 
FHA alone.
5.4.B. Effect of B.pertussis LPS on neutrophil
chemiluminescent response to intact B.pertussis
B .pertussis LPS induces neutrophil chemiluminescence 
directly (table 18) and enhances the neutrophil 
chemiluminescent response to fMLP (figure 8), so the effects 
of LPS on the neutrophil chemiluminescent response to intact 
B .pertussis were investigated (figure 18). A dose of 10 
pg of B .pertussis LPS induced a greater rate of 
chemiluminescence production accompanied with an apparent 
decrease in the chemiluminescence peak value and total 
chemiluminescence production (P<0.05). The effects noted were 
similar to those observed after neutrophil pre-treatment with 
FHA (figure 17). Thus, the decreased chemiluminescence peak 
value and total chemiluminescence production of the 
LPS-treated neutrophils may also have been due to the sampling 
regime missing out the highest peak values of these cells. LPS 
induced neutrophil chemiluminescence even in the absence of 
any other stimulus (table 18). This may have influenced the 
results obtained with LPS in the presence of intact 
B.pertussis .
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Figure IB. The affect of B .pertussis LPS on neutrophil 
chemiluminescent response to intact X-mode B .pertussis Tohama 
Rabbit peritoneal neutrophils were pre-incubated in the 
presence of various doses of the toxin for 60 min before 
addition of the stimulus. No toxin was added to the control. 
The figure shown is representative of 4 separate experiments.
a = No stimulus, 
b = 10 pg LPS. 
c = 1 pg LPS. 
d = Control (buffer).
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5.4.7. Ratio of bacteria to neutroahil in the 
chemiluminesoBncB assau
The number of intact S .pertussis per neutrophil in the 
neutrophil chemiluminescence assay was unknown, so the number 
of bacteria per assay tube was determined. In preliminary 
experiments with B .pertussis Tohama X-mode as the test 
bacterium contamination of viable counts was frequently 
encountered because of the number of manipulations involved. 
To overcome this, a B .pertussis Tohama X-mode organism, 
resistant to nalidixic acid CHIC of 60 pg nalidixic acid 
ml” *- of Bordet-Gengou medium) , was used in the bacterial 
viable count assay. Nalidixic acid and one other antibiotic, 
cephalexin, were incorporated into the growth medium to 
minimise the risk of contamination. The results obtained 
indicated that the B.pertussis suspension used in the 
chemiluminescencB assays contained between 2.6-3.7x10% 
viable organisms ml” *- (table 31). Since only 50 pi 
of a similarly standardised suspension was used in the 
chemiluminescencB assay, the ratio of neutrophils to viable 
bacteria used in the chemiluminescencB assay could be 
calculated. The ratio was calculated to be between 13-18 
bacteria per neutrophil.
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Table 31
Estimation of the numbers of B .pertussis organisms in 
a suspension using the viable count technique.
Dilution C.F.U.*/0 .1 ml of dilution C.F.U. ml-i
1 2 3 4 Mean of original
1 in 2.5x10= s-con* s-con s-con s-con s-con —
1 in 2.5x10* 1052 945 1103 907 1022 2.5x10%
1 in 2.5x10= 149 127 153 IBB 149 3.7x10%
1 in 2.5X1CM» 13 14 13 18 15 3.5x10%
♦Colony-forming units. 
*Semi-confluBnt growth.
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DISCUSSION
The underlying theme of this work was the belief that 
B .pertussis infections may alter the behaviour of neutrophils 
and thereby contribute to the pathogenesis of whooping cough.
In particular, an impairment of neutrophil function may cause 
the host to become susceptible to secondary infections.
Neutrophils from various species were studied but those from 
the rabbit received most attention because of their ease of 
procurement. The aspects of neutrophil function which received 
attention were adhesion and the bactericidal response to fMLP 
and intact B .pertussis. The neutrophil aggregation assay 
measured changes in cell adhesion. The chemiluminescencB assay 
measured potential bactericidal capacity of the neutrophils.
Both culture supernate fractions and purified B .pertussis 
components were assayed for their effects on neutrophil 
aggregation and chemiluminescent response to fMLP. Both 
antigenically-modulated strains of and mutants of B .pertussis 
were assayed to find the role of virulence factors on 
neutrophil chemiluminescent response to intact B .pertussis . 
Purified virulence factors of B .pertussis were also assayed on 
neutrophil response to intact B .pertussis .
Part 1: The effect of B.pertussis products on neutrophil 
aooreoation
Aggregation involves changes in the adhesive properties of 
cells. Neutrophil adhesive changes are important during 
margination, locomotion, and for phagocytosis.
G . 1.1. Identification of active factorCs)
B . pertussis cytoplasmic and culture supernate fractions
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enhanced aggregation of rabbit peritoneal neutrophils and 
certain observations implicated PT as the causative factor.
For example, supernatant fractions of the virulent 
B .pertussis X-mode strain, which produces FT, had greater 
neutrophil aggregating activity than those of the avirulent 
B . pertussis C-mode strain, which is PT-deficient. In addition, 
both B .pertussis X- and C-mode supernatant fractions lost 
neutrophil aggregating activity after heating at 0O=C for 
30 mln, a treatment which destroys the activity of P T . 
Supernatant fractions of B .parapertussis, a species which does 
not produce PT, contained no detectable neutrophil aggregating 
activity. However, on more detailed investigation purified PT 
was less active at enhancing neutrophil aggregation than the 
B . pertussis X- or C-mode supernatant fraction, suggesting that 
PT was not the major factor in the B .pertussis supernatant 
fractions which enhanced neutrophil aggregation.
The B .pertussis X- and C-mode supernatant fractions were 
therefore examined for the presence of other factors which may 
have influenced neutrophil aggregation. The major candidates 
were adenylate cyclase, heat-labile toxin, LPS, and FHA. The 
heat-stable adenylate cyclase of B .pertussis has important 
anti-phagocytic properties (section 2.3.2.), and it has been 
suggested that the enzyme acts by inducing unregulated cAMP 
formation in phagocytes (Confer et. aj^ . , 1304). The agents
theophylline and caffeine raise neutrophil intracellular cAMP 
levels and both inhibited aggregation of rabbit peritoneal 
neutrophils. This suggested that B .pertussis adenylate cyclase 
would also inhibit neutrophil aggregation. The heat-stable 
adenylate cyclase of B .pertussis is resistant to heating at 
100°C for 5 min (Confer and Eaton, 1902), therefore the 
enzyme may be resistant to heating at 0O=C for 30 min.
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Weiss and Hewlett C19BG) recently reported that B .pertussis 
produces two Forms of adenylate cyclase; adenylate cyclase 
enzyme and adenylate cyclase toxin. The adenylate cyclase 
enzyme was originally isolated from culture supernates of 
B .pertussis. has enzymic activity, and has no effect on 
eukaryotic cells. The adenylate cyclase toxin also has enzymic 
activity, but is mainly cell-associated and has the ability to 
enter eukaryotic cells and catalyze the formation of cAMP. If 
sufficient of the latter form of adenylate cyclase was present 
in the B .pertussis X- or C-mode supernatant fractions then 
inhibition of neutrophil aggregation would have been observed 
after heat-treatment CBO=C for 30 min) of the fractions. 
Heat-treated B .pertussis X- and C-mode supernatant fractions 
did not inhibit neutrophil aggregation suggesting that there 
was little or no active, heat-stable adenylate cyclase present 
in the B .pertussis supernatant fractions. This was confirmed 
by direct enzymic assays: there was no adenylate cyclase 
activity detectable in either the B .pertussis X- or C-mode 
supernatant fraction. Low levels of adenylate cyclase activity 
were, however, found in a S .parapertussis X-mode supernatant 
fraction. The B .parapertussis X-mode supernatant fraction had 
no significant effect on neutrophil aggregation suggesting 
that there was insufficient levels of adenylate cyclase toxin 
present to influence aggregation.
B .pertussis adenylate cyclase enzyme is extracellular and 
it is perhaps surprising that little or no cyclase activity 
was found in the supernatant fractions isolated. This is 
explicable: since the supernatant fractions used in the 
experiments were of molecular mass > 100 kOal whereas the 
molecular mass of the cyclase found in culture supernates is 
70 kOal, one would expect to find very little adenylate
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cyclase activity in the supernatant fractions used. In 
addition, the fractionation procedures destroy adenylate 
cyclase activity (Hewlett and Wolff, 197B). Although adenylate 
cyclase activity was not detected in the B .pertussis 
supernatant fractions, low levels were found in a more 
concentrated sample of the B ■parapertussis X-mode supernatant 
fraction. B.parapertussis produces greater levels of 
extracellular adenylate cyclase than B .pertussis CEndoh ej^  
al., 1980) and this may explain why adenylate cyclase
activity was found in supernatant fractions of the former but 
not the latter organism.
Purified adenylate cyclase was not assayed for its effects 
on neutrophil aggregation since no purified enzyme was 
available. The purification procedures used for isolation of 
B . pertussis adenylate cyclase are complex and time-consuming.
In addition, the adenylate cyclase isolated from Sordetella 
culture supernates has no effect on eukaryotic cells (Weiss 
and Hewlett, 1986).
The supernatant fractions were also assayed for heat-labile 
toxin, but no toxin activity was found. It is probable that 
the toxin was not detected because it is an intracellular 
protein (Cowell et al., 1979) and is not likely to be present
in significant levels in 40 h culture fluids. If heat-labile 
toxin was the factor responsible for inducing aggregation then 
B .parapertussis supernatant fractions should also have had 
aggregating activity.
Another toxin, LPS, was found as a major component in both 
the X- and C-mode B .pertussis supernatant fractions using 
SDS-PAGE. Significantly, the C-mode fraction contained more 
LPS than the X-mode fraction, as estimated by SDS-PAGE, but 
had lower neutrophil aggregating activity. Purified
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B .pertussis LPS did not influence aggregation. In addition, 
smooth and rough LPS from Salmonella Minnesota and 
Salmonella Minnesota ReSSS respectively did not influence 
aggregation. This suggested that LPS had no influence on 
aggregation under the conditions used. This agrees with the 
findings of Dahinden and Fehr (1983) who reported that 
Salmonella LPS did not induce granulocyte aggregation, as 
measured by an aggregometer. The above results differ from the 
findings of Thorne ejt (1977) who, using a similar
aggregation assay to that used in the present investigation, 
suggested that LPS from Acinetobacter species enhanced rabbit 
peritoneal neutrophil aggregation. The difference in results 
may be explained by the different species of LPS used.
FHA was the most active bacterial component tested in the 
neutrophil aggregation assay, suggesting that it was 
responsible for the neutrophil aggregating activity present in 
the B .pertussis supernatant fractions. In addition, like the 
activity in the supernatant fractions, the neutrophil 
aggregating activity of purified FHA was destroyed by 
heat-treatment at 80=C for 30 min. Surprisingly, no neutrophil 
aggregating activity was found in any of the B .parapertussis 
supernatant fractions. B .parapertussis has a faster growth 
rate than B .pertussis and FHA production by B .parapertussis 
may have been suppressed at an earlier stage during the 48 h 
incubation period than FHA production by B .pertussis. Any FHA 
produced by B .parapertussis would have been subjected to 
prolonged mechanical, and possibly chemical, degradative 
processes which may have destroyed the neutrophil aggregating 
activity.
The results suggested that B .pertussis produces two 
neutrophil aggregating factors, FHA and P T . To investigate
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whether the PT preparations were contaminated by a trace 
amount of FHA, the toxin preparations were examined by 
SDS-PAGE and FHA ELISA. SDS-PAGE showed one or more 
contaminating bands in the PT preparations used. It is 
possible that the contaminating bands (except the LPS band) 
were breakdown products of FHA and that they may have been 
responsible for the neutrophil aggregating activity credited 
to PT. This is not implausible since it would only require 
about 4-5% contamination of the PT preparations by FHA. 
However, an FHA ELISA of both PT preparations indicated that 
no FHA was present in either sample. The FHA ELISA utilised 
the monoclonal antibody F 3 . Irons et. al_. (1303) 
reported that this monoclonal fails to detect SDS-dissociated 
FHA and suggested that F3 may be directed against a 
conformational determinant of FHA. If some of the 
contaminating bands present in the PT preparations were FHA 
fragments, then the conformation of the FHA molecule, and 
possibly the F3 receptor, may have been altered. This would 
explain the apparent absence of immunologically-reactive FHA 
in the PT sample assayed. It may also explain why the FHA 
ELISA results indicated that there was no detectable FHA 
present in either the B .pertussis X- or C-mode supernatant 
fraction. No bands, except LPS, were observed in SDS-PAGE 
profiles of either B .pertussis X- or C-mode supernatant 
fraction. However, the protein concentration of each 
supernatant fraction sample loaded onto the gel was very low 
(1.5 pg) and a small amount of FHA may have been below the 
level of detection. Concentration of the B .pertussis 
supernatant fractions by membrane dialysis may have allowed 
visualisation of any proteins present by SDS-PAGE. The 
question of FHA contamination might have been resolved had
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other monoclonal antibodies, which would react with denatured 
FHA, been available. These could have been used as a FHA probe 
in either an ELISA or in an immunoblotting technique. One 
indication that FHA and PT may both enhance neutrophil 
aggregation is the difference in neutrophil
species-specificity observed for each B .pertussis component 
(see section 6.1.2.).
The various activities of PT depends on at least two 
mechanisms: the ADP-ribosyItransferase activity of the 'A' 
moiety or the binding of the 'B ' moiety to the cell surface 
(Nogimori e^ aJL' , 1984) . The ADP-ribosylating activity of the 
toxin was reviewed in section 2.1.4.; the 'B ' moiety interacts 
with lymphocytes inducing lymphocytosis-promotion and a 
mitogenic response (Nogimori at. aJL. , 1994). If the 'B ' moiety 
of the toxin was responsible for enhancing neutrophil 
aggregation then two possible processes may be visualised. The 
neutrophils may be passively agglutinated by cross-linking of 
the cells by toxin. Alternatively, the binding of PT to 
neutrophils may stimulate neutrophil adhesiveness and thus 
agglutination, possibly by the induction of neutrophil 
secretion. A mixture of both passive and stimulated 
agglutination may even be involved. The enhancement of 
neutrophil aggregation by FHA may also be mediated by similar 
processes.
The chemiluminescence results showed that PT inhibited, 
whereas FHA enhanced, neutrophil bactericidal responses. The 
bactericidal responses of neutrophils normally involves 
degranulation. Possibly FHA-enhancement of neutrophil 
aggregation was due to induction of neutrophil secretion by 
FHA. Since PT actually inhibits neutrophil secretory responses 
(Becker at gj,., , 1986) this suggests that any PT-enhancement
144
□f neutrophil aggregation is due to passive cross-linking of 
the cells by toxin. A similar aggregation response, the 
clumping of Chinese hamster ovary cells, also occurs in the 
presence of PT and has been used as an in. vitro assay for 
the toxin. The clumping of these cells is not due to passive 
agglutination, nor alteration of the basal cyclic AMP levels 
of the cells, and it has been suggested that a toxin-mediated 
alteration of the cell surface occurs (Hewlett et aJL.. , 1983) .
Although both FHA and PT enhanced neutrophil aggregation,
FHA was more active than PT . FHA is also a more active 
haemagglutinin than P T . A third haemagglutinin of B .pertussis 
has been reported CKawai et, aj^ . , 1302) . This haemagglutinin
was extracted from whole-cells of B .pertussis. induced strong 
agglutination of human erythrocytes, and was thought to 
correspond to an ornithine-containing lipid. The effects of 
this proposed haemagglutinin on neutrophil aggregation is 
unknown.
6.1.2. Interspecies differences in neutrophil response to 
active factor(s)
A noteworthy observation was the apparent 
species-specificity of the aggregation response. Rabbit 
neutrophils were sensitive to the aggregating factor(s) in the 
B . pertussis X- and C-mode supernatant fractions whereas human 
and pig neutrophils were not. FHA also showed a similar 
pattern since it enhanced the aggregation of rabbit but not 
human neutrophils. FHA has an affinity for cholesterol (Irons 
and MacLennan, 1973) and the cholesterol content of the 
neutrophil surface may determine the species-specificity of 
FHA-induced aggregation. Whether or not the outer membranes of
145
rabbit and human neutrophils differ in their cholesterol 
content has not been reported. Alternatively, FHA may bind 
equally well to the different neutrophil species but with 
rabbit cells being the most sensitive to the subsequent 
effects of FHA, Purified PT showed no species-specificity; the 
toxin appeared to enhance aggregation of both rabbit and human 
neutrophils. The aggregation of rabbit peritoneal neutrophils 
was enhanced more than that of rabbit peripheral neutrophils 
by all active bacterial samples tested. Rabbit peritoneal 
neutrophils are more adhesive than rabbit peripheral cells 
in vitro (Bamberger ejt , 1905), which may explain the
differences observed.
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Part 2: The effect of B.pertussis components on ths
chemiluminescent response of neutrophils to fMLP
ChemiluminescencB is an indirect measure of the bactericidal 
capacity of phagocytes. M=Call et ai* C1973) reported 
that the responses induced by fMLP in neutrophils are similar 
to those induced during an acute bacterial infection. Thus, 
alteration of neutrophil responses to fMLP may indicate an 
alteration of the normal neutrophil responses to infection.
6.2.1. Enhancing effect of filamentous haemagglutinin and 
LPS
Both the FHA and LPS of B .pertussis enhanced the 
chemiluminescence of rabbit peritoneal neutrophils in response 
to the pro-inflammatory mediator fMLP. There was a lag period 
of about 15 min before any FHA- or LPS-induced enhancement of 
chemiluminescence was observed. The minimum doses of FHA and 
LPS which caused a significant enhancement were 10 ng and 1 pg 
respectively. Both components caused a slight, but 
significant, stimulation of neutrophil chemiluminescence in 
the absence of fMLP. This is the first report of the effect of 
FHA on neutrophil repense to a pro-inflammatory mediator,
The summed levels of neutrophil chemiluminescence generated 
in the presence of both fMLP and FHA or fMLP and LPS were 
significantly higher than the summed levels of neutrophil 
chemiluminescence generated in the presence of fMLP alone plus 
that of FHA or LPS alone. This suggests that there may be 
synergism between fMLP and FHA or LPS. Noticeably, there was a
correlation between direct stimulus of neutrophil
chemiluminescence by FHA or LPS in the absence of fMLP with
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enhancement of chemiluminescancB by FHA or LPS in the presence 
of fMLP. The rough LPS of E .coli J5, which contains only 
core glycolipid, and the smooth LPS of E .coli 0111:84 were 
both capable of inducing human neutrophil chemiluminescence 
directly in the presence of luminol CHenricks et al,, 1383). 
This agrees with the present results showing that LPS caused a 
direct induction of chemiluminescence of rabbit peritoneal 
neutrophils. Henricks et. al^ . C1303) reported that smooth 
E .coli LPS generated less chemiluminescence from human 
neutrophils than rough E .coli LPS. A similar pattern was found 
with Salmonella minnesota rough or smooth LPS and rabbit 
peritoneal neutrophils in the present work. Fish gt. aj,.. (1307) 
suggested that FHA is the cell surface moiety responsible for 
hydrophobic adherence in B .pertussis. Possibly the interaction 
of neutrophils with both B .pertussis LPS or FHA is mediated 
by a similar non-specific, hydrophobic interaction and this 
may explain why both components had a similar effect on the 
chemiluminescent response of neutrophils to fMLP. Proctor 
(1373) reported that E .coli 0111:84 LPS did not induce 
chemiluminescence of human peripheral neutrophils directly. 
However, this study was done in the absence of luminol, which 
reduces the sensitivity of the method.
It would be of interest to know whether the neutrophil 
chemotactic response to fMLP is also influenced by FHA or LPS 
pre-treatment. Studies on the influence of FHA or LPS on 
neutrophil chemiluminescent response to other pro-inflammatory 
mediators (CSa or leukotriene B4) or phorbol myristate acetate 
may have given more information on how these B .pertussis 
components interact with neutrophils. If FHA or LPS also 
enhance the neutrophil chemiluminescent response to CSa and 
leukotriene B4, then this suggests that the B ■pertussis
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components are not exerting their effects solely by 
interfering with the fMLP receptor. Phorbol myristate acetate 
is a tumour-promoting agent which appears to exert its effects 
by activating the protein kinase C in target cells (Nishizuka, 
1904). Information on the effect of FHA or LPS on phorbol 
myristate acetate-induced chemiluminescence of neutrophils may 
indicate whether protein kinase C activation was affected by 
FHA or LPS-treatment. Interestingly, PT inhibits neutrophil 
responses to fMLP, CSa, and leukotriene B4, but has no 
influence on neutrophil response to phorbol myristate acetate 
(Becker at gl_. , ISBB) . This shows that bacterial components 
can affect some components of the neutrophil signal 
transduction pathways but not others.
6.2.2. Inhibition of neutrophil chemiluminescence bu 
pertussis toxin
PT suppresses certain neutrophil responses to fMLP and 
several other chemotactic factors (section 2.3.3.). The 
microbicidal responses of phagocytes can be separated into two 
processes: degranulation and the oxidative respiratory burst. 
The oxidative respiratory burst can be further separated into 
two processes: myeloperoxidase-associated reactions and 
reactions involving the generation of reactive oxygen 
radicals. PT inhibits both fMLP-induced neutrophil 
degranulation (Becker et gl_. , 1985) and generation of the
reactive oxygen radical superoxide (Lad et^  aj^ . , 1085). The 
effect of PT on neutrophil myeloperoxidase-associated 
reactions induced by fMLP has not been reported. 
Luminal-enhanced neutrophil chemiluminescence is dependent on 
a myeloperoxidase-associated reaction (DeChatelet et . ,
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1982). The present results show that PT inhibits 
FMLP-induction of rabbit peritoneal neutrophil 
chemiluminescence in the presence of luminol. Thus, the 
myeloperoxidase-associated microbicidal responses of 
neutrophils induced by fMLP are also inhibited by PT .
PT ADP-ribosylates a membrane protein of molecular mass 
about 41 kDal in neutrophils CBokoch and Gilman, 1904). This 
protein is a G-protein which is immunochemically distinct from
Gi, Go, and transducin CGierschik at ai.-, 19BG). It has been 
suggested that this G-protein couples receptor-chemotactic 
factor interaction to phospholipase C activation (Becker at 
al.. 1905; Bradford and Rubin, 190G). Thus, the inhibitory 
effects of PT on neutrophil response to fMLP may be due to 
ADP-ribosylation of a membrane protein which links the 
fMLP-receptor signal to phospholipase C activation. PT has no 
effect on either the number or affinity of the formy1-peptide 
receptors on neutrophils (Becker et al.. , 1905) supporting 
the theory that the fMLP-receptor signal transduction is 
impaired by PT-treatment.
FHA enhanced neutrophil chemiluminescent response to fMLP. 
Both FHA and PT are haamagglutinins and may induce similar 
responses in other cells. The haemagglutinating activity of PT 
resides in the B-oligomer of the toxin (Nogimori et. aJL. ,
1904). The ADP-ribosylating activity of the toxin is found in 
the A-protomer of the toxin (Tamura et al. , 1982). It would 
be of interest to assay the effect of purified B-oligomer of 
PT on neutrophil chemiluminescent response to fMLP in order to 
show whether this component alone, minus the inhibitory 
capacity of the A-protomer, enhances neutrophil 
chemiluminescence. FHA required only 15 min before an 
enhancing effect was observed. No enhancement of neutrophil
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chemiluminescent response to FMLP by PT was observed before 
the inhibitory response of the toxin was noted after 30-40 min 
incubation with the neutrophils. This suggests that the 
binding of the B-oligomer of PT to the neutrophil outer 
membrane does not enhance neutrophil chemiluminescent response 
to fMLP. The binding of the B-oligomer of PT is required for 
the A-protomer to reach its site of action in target cells 
(Nogimori at. al., , 1904). Thus, pre-incubation of neutrophils 
with only the A-protomer of PT would be unlikely to have 
inhibitory effects on neutrophil chemiluminescent response to 
fMLP.
The chemiluminescence studies showed that inhibition of 
fMLP-induced chemiluminescence of rabbit peritoneal 
neutrophils by PT was detectable down to about 5 ng of toxin 
per vial. In its present form, an assay of PT-induced 
inhibition of neutrophil chemiluminescent response to fMLP is 
not as sensitive as the Chinese hamster ovary cell assay for 
P T . The latter assay involves a visual scoring of cell 
clustering induced by toxin-treatment and has been reported to 
detect toxin concentrations as low as 0.12 ng ml"*- (Hewlett et 
al. ■ 19B3). However, by the use of more cells, a higher 
concentration of luminol and by optimising the fMLP dose, the 
sensitivity of the chemiluminescence assay could probably be 
improved. Chemiluminescence has the advantages of being a 
faster and simpler technique than the Chinese hamster ovary 
cell assay; the former assay takes between 1-2 h whereas the 
latter assay takes between 16-24 h. In addition, 
chemiluminescencB is less subjective and does not involve the 
possibility of human bias in scoring results.
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G.2.3. Pertussis toxin suppression of FHA- and LPS-enhancement
oF neutrophil chemiluminescent response to FMLP
One of the most significant observations in this study was 
that PT inhibited whereas FHA and LPS enhanced rabbit 
peritoneal neutrophil chemiluminescent response to fMLP. 
Experiments were performed to see whether the effect on 
neutrophil chemiluminescence of the inhibitor, PT, or an 
enhancer, FHA or LPS, would predominate in a mixture of both. 
This is relevant to the question of which factor may 
predominate in. vivo. The PT inhibitory effect overrode the 
enhancing effect of either FHA or LPS. This indicated that the 
capacity of both FHA and LPS to enhance the fMLP-induced 
chemiluminescence response was probably mediated mainly via 
the same pathway as the fMLP-receptor signal. Since PT could 
not totally inhibit the enhancing response of FHA or LPS, this 
may indicate that FHA and LPS are also causing 
chemiluminescence via some other route insensitive to 
inhibition by P T . Both FHA and LPS are capable of promoting 
neutrophil chemiluminescence directly. Thus, the use of PT as 
a probe suggests that the enhancement of neutrophil 
chemiluminescence by either FHA or LPS in the presence of fMLP 
is the sum of two different effects; one transduced by the 
same pathway as the fMLP-receptor signal and the second rather 
minor effect by some other pathway.
The inhibition of neutrophil chemiluminescent response to 
fMLP by a component, presumably PT, of an acellular pertussis 
vaccine was abolished after the vaccine was toxoided. The 
toxoided vaccine enhanced neutrophil chemiluminescent response 
to fMLP and FHA was implicated as the factor responsible. The 
results suggest that neutrophil chemiluminescent response to
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fMLP can be used as a method of monitoring the toxoiding of an 
acellular pertussis vaccine.
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Part 3: Neutrophil chemiluminescent response to whole-cells 
of B.pertussis
The bactericidal response of neutrophils against intact 
B.pertussis was measured using chamiluminescance. Inhibition 
of neutrophil bactericidal response to B .pertussis would be 
of obvious survival advantage to the bacteria iji vivo. The 
effect of individual B .pertussis components on neutrophil 
chemiluminescent response to whole-cells of B .pertussis was 
investigated using antigenically-modulated strains, 
transposon-induced mutants deficient in one or more virulence 
factors, and purified components of B .pertussis .
6.3.1. Effect of B.pertussis antigenic modulation
B . pertussis 18334 and Tohama X-mode strains induced higher 
levels of rabbit peritoneal neutrophil chemiluminescence than 
their respective C-mode strains. There was a positive 
correlation with strain hydrophobicity; both X-mode strains 
were significantly more hydrophobic than either C-mode strain. 
This agrees with the findings of Robinson e^ C19B3)
who also reported that B .pertussis becomes more hydrophobic 
during C- to X-mode variation.
The association of Escherichia coli with neutrophils, in 
the absence of antibodies and complement, is governed by 
hydrophobic interactions and mannose-specific structures such 
as type-1 fimbriae COhman et aT. , 1985). Topley et. aJt- (1984) 
reported that the high surface hydrophobicity of unopsonized 
E .coli was associated with expression of type-1 fimbriae and 
the induction of a strong neutrophil chemiluminescent 
response. In addition, when fimbriation was suppressed the
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bacteria became more hydrophilic and the neutrophil 
chemiluminescent response was greatly diminished. Filiation 
and hydrophobicity of non-mucoid Pseudomonas aeruginosa 
has been positively correlated with the susceptibility of the 
bacterium to phagocytosis CSpeert ejt aX- , 19SB) . The 
neutrophil chemiluminescence experiments with B .pertussis 
were performed in the absence of antibodies and complement.
The hydrophilicity results suggest that hydrophobic 
interactions may also be important in the association of 
B . pertussis with neutrophils. Fish et a_L. (1987) reported 
that FHA is the cell surface moiety responsible for 
hydrophobic adherence in B .pertussis. However, FHA is not a 
fimbrial component (Ashworth et ai.., 1982b). Thus, the loss of
FHA from the cell surface of B .pertussis may account for the 
increased hydrophilicity of the C-mode strains and the poor 
capacity of these strains to stimulate neutrophil 
chemiluminescence.
A microorganism can sometimes avoid killing by phagocytes by 
avoiding phagocytosis. A correlation between increased 
bacterial hydrophilicity and increased resistance to 
phagocytosis by rabbit peritoneal neutrophils has been 
reported with Salmonella tuohimurium (Stendahl et. ,
1973). The smoothness of Salmonella tuohimurium LPS appeared 
to be an important factor in determining the organism’s 
hydrophilicity and resulting resistance to phagocytosis. The 
LPS of (virulent) phase I and (avirulent) phase IV 
B .pertussis are similar (Le Dur et a l ., 1980). This suggests
that the LPS of B .pertussis would not change during antigenic 
modulation, and that changes in LPS are not responsible for 
the changes observed in cell hydrophilicity during antigenic 
modulation.
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Neutrophil chemiluminescence has been associated with direct 
bacterial killing CHoran ejt. ai.-• 1982). Increased production 
of neutrophil chemiluminescence thus probably indicates 
increased levels of killing. The chemiluminescence results 
appear to indicate that rabbit peritoneal neutrophils might 
take up and kill X-mode organisms more easily than they kill 
C-mode organisms. This is contrary to the known virulence of 
the strains; X-mode organisms are more virulent than C-mode 
organisms CLacey, I860; Idigbe et, al.-, 1981). X-mode strains 
have at least two factors (adenylate cyclase and PT) which can 
interfere with neutrophils. This suggests that since X-mode 
strains are virulent, adenylate cyclase and PT must be of 
prime importance in. vivo .
The chemiluminescence studies were done with unopsonized 
B .pertussis organisms. However, B .pertussis may be opsonized 
prior to encounters with neutrophils iri vivo. Opsonized 
B . pertussis induce higher levels of neutrophil 
chemiluminescence production than unopsonized B .pertussis 
(Pertilla et a4_. , 1306). In the presence of serum opsonins,
the neutrophil chemiluminescence patterns for the X- and 
C-mode organisms may be altered. The expected pattern of a 
negative correlation of B .pertussis virulence with 
neutrophil chemiluminescent response to whole-cells of 
B . pertussis may then be observed. Murine alveolar macrophages 
phagocytosed and killed opsonized B .pertussis phase IV 
organisms more easily than phase I organisms (Muse et. aj^ . ,
1973). This suggests that a similar correlation with virulence 
would be found with antigenically-modulated B .pertussis 
strains.
Opsonization may be important in determining the interaction 
of S . pertussis with neutrophils. The opsonization of smooth
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Salmonella tuohimurium by IgB and complement increased the 
organism’s hydrophobicity and susceptibility to phagocytosis 
(Stendahl, 1903). However, the binding of secretory IgA to 
rough Salmonella tuohimurium bacteria reduces the hydrophobic 
interaction of the organism with neutrophils, making the 
organism less likely to be phagocytosed (Magnusson et ,
1979). B .pertussis is a pathogen of the upper respiratory 
tract and IgA antibodies may be implicated in early immunity 
to pertussis and in the prevention of attachment (Bienenstock 
and Befus, 1900; Manclark and Cowell, 1904). The titres of 
IgA, IgG, and IgM against FHA increase during a natural 
pertussis infection (Granstrom et_ gJL. , 1902). Burstyn et al . 
(1903) reported that IgA against FHA and LPS was present in 
convalescent sera and suggested that this may be presumptive 
evidence of recent pertussis infection. Thus, specific 
antibodies and complement are presumably also very important 
in determining the interaction of B .pertussis with 
neutrophils, and not simply hydrophobicity.
The effects of B .pertussis virulence factors on neutrophils 
are of obvious importance and should be taken into 
consideration when analysing the neutrophil chemiluminescence 
patterns induced by whole-cells of B .pertussis. Thus,
B . pertussis Tohama mutants, deficient in one or more 
virulence factors and grown in X-mode, were assayed to 
determine the contribution of each virulence factor to the 
neutrophil chemiluminescence pattern obtained for the virulent 
parental organism. The adenylate cyclase- and
haemolysin-deficient strain B .pertussis 340, the FHA-deficient 
strain B .pertussis 353, and the PT-deficient strain 
B .pertussis 357 induced similar chemiluminescence peak 
values which were not significantly different. All three
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strains induced iaiuci' chemiluminescence peak values compared 
to the virulent B .pertussis parental strain. The loss of one 
or two virulence factors by the mutants may have lessened the 
surface hydrophobicity of the organism making the organism 
more hydrophilic and therefore resistant to neutrophil 
interaction. However, the hydrophilicity values obtained for 
the parental strains and the three mutant strains 
B ■ pertussis 348, 353, and 357 were not significantly 
different. This is contrary to the findings of Fish ejt al. 
(1987) who reported that B .pertussis strains deficient in FHA 
had increased hydrophilicity when compared to the parental 
strain which produced FHA. The hydrophilicity assay used for 
the present study may not have been sensitive enough to 
differentiate small differences in hydrophilicity, which may 
have been more readily detected by the differences observed in 
the neutrophil chemiluminescence studies. The avirulent strain 
B . pertussis 347 is very similar to a C-mode organism since 
both organisms are deficient in a range of virulence factors. 
The hydrophilicity value of B .pertussis 347 and the neutrophil 
chemiluminescence induced by the organism were similar to 
those of both B .pertussis Tohama or 18334 C-mode organisms.
The adenylate cyclase- and haemolysin-deficient strain,
B .pertussis 348, induced lower levels of neutrophil 
chemiluminescence than the parental strain which produced both 
adenylate cyclase and haemolysin. This was contrary to 
expectations; presence of adenylate cyclase would be expected 
to cause a decrease in neutrophil chemiluminescence induced by 
intact bacteria. Studies by Confer and Eaton (1902) suggested 
that B .pertussis adenylate cyclase toxin inhibited both 
neutrophil killing of bacteria and induction of 
luminol-enhanced chemiluminescence by opsonized zymosan. The
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protein concentration of the most active crude adenylate 
cyclase preparation they used to obtain an inhibitory effect 
on chemiluminescence was between about 2-32 pg ml” *-. The 
protein concentration per vial of the intact B . pertussis 
suspension used in the present chemiluminescence studies was 
about 11 p g . Any inhibitory effect of the adenylate cyclase 
toxin would probably be undetectable at such low protein 
concentrations. In addition, the bacteria used in the present 
study had been washed, a process which could have removed any 
surface-bound adenylate cyclase.
The effect of PT or FHA on neutrophil chemiluminescent 
response to whole-cells of bacteria has not been reported 
previously. Therefore, before any conclusions on the 
chemiluminescence patterns of the PT-deficient or 
FHA-deficient strains can be made, the effect of each 
component on chemiluminescence induced by whole-cells of 
B .pertussis must be determined. The results of such 
experiments are discussed in section 6.3.2.
6.3.2. Effect of purified virulence factors
PT in this study had a slight inhibitory effect on the 
neutrophil chemiluminescent response to whole-cells of 
B . pertussis. Possibly, this inhibition by PT reflects a 
partial suppression of phagocytosis which would be of 
advantage to the pathogen. Studies on the effect of PT on 
phagocytosis by other cell types have been performed, but the 
results appear contradictory. Meade et al.. C1304) reported 
that PT inhibited phagocytosis by murine macrophages. However, 
Lad ejt (1986) reported that PT did not influence
phagocytosis by human neutrophils. Differences in these
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reports may reflect variations between the cell types used and 
in the experimental procedures.
The PT-deficient strain B .pertussis 357 did not induce 
greater chemiluminescence production or higher 
chemiluminescence peak values than the virulent parental 
strain. This is perhaps surprising since the toxin 
individually caused an overall inhibition of neutrophil 
chemiluminescence. FHA-treated neutrophils produced 
chemiluminescence more rapidly than untreated cells when 
intact B .pertussis was used as a stimulus. The rate of 
chemiluminescence production induced by the FHA-deficient 
strain B .pertussis 353 was similar to the parental strain 
which produced FHA. Perhaps the chemiluminescence assay was 
not sensitive enough to detect the influence of the low 
concentrations of PT or FHA found on whoie-cells of 
B .pertussis. The results suggest that the way in which 
individual B . pertussis components, such as PT and FHA, are 
expressed on the bacterial cell surface may also influence the 
chemiluminescence patterns induced by whole-cells of 
B .pertussis.
B .pertussis LPS was assayed for its effects on neutrophil 
chemiluminescent response induced by intact B .pertussis . No 
studies of the effects of B .pertussis LPS on phagocytes have 
been reported previously. LPSs from other organisms have a 
variety of effects on phagocyte function. For example,
E.coli D111 :BH LPS inhibited phagocytosis of opsonized 
microorganisms by both human neutrophils CHenricks e;t , 
1S83) and human macrophages in vitro (Davis nL al_. , 1980) .
Cohn and horse (1960) reported that Salmonella abortus enui 
LPS enhanced killing of Staohulococcus albus by rabbit 
peritoneal neutrophils in the presence of 10% serum, but
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reduced killing in the presence of 1% serum. In the present 
investigation, B .pertussis LPS inhibited the neutrophil 
chemiluminescent response to unopsonized, whole-cells of 
B. pertussis.
It would be of interest to study the effects of various 
toxins of B .pertussis on direct killing of B .pertussis by 
neutrophils. In addition, killing studies using
antigenically-modulated strains and transposon-induced mutants 
of B .pertussis could be performed. Any results from such 
experiments could be compared with the present 
chemiluminescence results. Preliminary studies had shown that 
following incubation of B .pertussis with neutrophils, any 
ingested bacteria could be liberated by lysis of the 
neutrophils with saponin, an agent with an affinity for 
cholesterol. This lysis procedure did not influence the 
viability of the bacteria (data not shown). After neutrophil 
lysis, the viable count of the bacteria (section 4.15.) and 
the rate of bacterial killing could be obtained. For this 
assay it would probably be advantageous to use the nalidixic 
acid-resistant B .pertussis Tohama strain to minimise 
contamination.
Thus, the results indicate that the neutrophil 
chemiluminescence pattern induced by an individual bacterial 
strain, in the absence of opsonins, is highly dependent on 
physicochemical factors such as hydrophobicity. Other 
physicochemical aspects which may also influence the 
chemiluminescence results obtained for the intact bacterial 
studies include the surface charge of the organism (Stendahl, 
1383). At the bacteria to neutrophil ratio used, no influence 
of bacterial-associated virulence factors on neutrophil 
chemiluminescence pattern generated was detected. However,
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using purified virulence factors, different components of 
B .pertussis had effects on neutrophil chemiluminescent 
response to intact B .pertussis. The neutrophil 
chemiluminescence patterns induced by the different 
B .pertussis mutants may have been influenced by how the 
individual virulence factors are expressed by the bacteria. In 
conclusion, the neutrophil chemiluminescent response to 
bacteria appears to depend on both the physicochemical nature 
of the surface of the bacteria and on expression of the 
different virulence factors by the bacteria.
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Part 4: The potential significance of the results on 
neutrophil responses in vivo
6.4.1. Importance of neutrophils in the control of 
resoiratoru tract infections
In humans, the inhibition of normal neutrophil responses by 
B .pertussis factors may be responsible for the host’s 
susceptibility to pertussis and other secondary infections.
The lodgement and replication of B .pertussis in the upper 
respiratory tract would probably initiate an inflammatory 
response, with the subsequent recruitment of neutrophils to 
the infected area. The production of anti-neutrophil factors 
by B .pertussis may therefore be important in pathogenesis of 
the disease.
The role of phagocytes in controlling upper respiratory 
tract infections has been poorly studied. Studies have tended 
to concentrate on the lower respiratory tract and on the role 
of pulmonary alveolar macrophages in the control of infection 
in this area (Green ^  gJL. , 1977; Huber et gT . , 1977).
However, certain observations suggest that neutrophils are 
also important in fighting infections of the respiratory 
tract. For example, patients with neutrophils which have 
chemotactic disorders are prone to recurrent respiratory 
infections including rhinitis and pneumonia (Gallin e^ , 
1300; Smith et_ g_l_. , 1972). Various studies have indicated
that neutrophils are crucial in the early clearance of 
nontypable Haemophilus influenzae from murine lungs (Toews e_t 
ai . , 1985). Granulocytes are also recruited to the murine
lung in the early clearance of Streptococcus pneumoniae and 
bacterial clearance is reduced in neutropenic animals
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CHeidbrink sT ., 1900). Both H .influenzae and S .pneumoniae
can superinfect pertussis patients (Jamieson, 1373). Possibly 
inhibition of neutrophil responses by B .pertussis virulence 
factors contributes to the host’s susceptibility to secondary 
infections by these and other organisms.
The majority of the studies performed were done using rabbit 
neutrophils. The human is the natural host for B .pertussis 
and the mouse is the most commonly used animal model for 
pertussis. Thus, the use of human or murine neutrophils would 
have made the results easier to discuss in relation to the 
human situation. However, Preston e;t (1380) suggested
that pernasal pertussis infection in the rabbit would be more 
appropriate than murine intracerebral infection for a study of 
immunity to pertussis in the human child. In addition, rabbits 
have been infected with B .pertussis with the subsequent 
development of an upper respiratory tract infection (Ashworth 
et al.. 1382a). Human neutrophils were difficult to obtain 
and murine neutrophils could not easily have been obtained in 
sufficient numbers to complete the quantity of assays 
performed using rabbit neutrophils. Thus, rabbit neutrophils 
were perhaps the next most appropriate experimental animal 
species to use for the studies performed.
B.4.2. Alteration of normal neutrophil responses bu 
B.pertussis components
FHA had profound effects on rabbit neutrophil function. The 
aggregation of rabbit peritoneal and peripheral neutrophils 
was enhanced by FHA treatment which could indicate that 
margination and locomotion of rabbit neutrophils may be 
altered ijj vivo. FHA did not influence human peripheral
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neutrophil aggregation although this does not rule out that it 
may influence human exudate neutrophil aggregation. During a 
pertussis infection, any neutrophils which were recruited to 
fight infection would of necessity have undergone emigration. 
PT appeared to enhance the aggregation of both rabbit and 
human neutrophils although relatively higher doses of toxin 
than of FHA were required to enhance rabbit peritoneal 
neutrophil aggregation. If PT does influence the aggregation 
of human peripheral neutrophils, it may alter the adhesive 
properties of the neutrophils in. vivo. Thus, the alteration of 
neutrophil adhesiveness by circulating FHA or PT could inhibit 
neutrophil margination and locomotion rn vivo thereby 
prolonging the survival of B .pertussis in the host.
FHA has been implicated as a potential adhesin of 
B . pertussis iri vitro CFish et aT . , 1SB7) and may be an
important adhesin in_ vivo CTuomanen and Weiss, 1985). Scheffer 
et al . (1985) suggested that bacterial adhesins have a 
patent role in inducing the release of inflammatory mediators 
from neutrophils. My results show that FHA enhanced the 
chemiluminescent response of rabbit peritoneal neutrophils to 
a pro-inflammatory mediator (fMLP). In addition, FHA induced 
the chemiluminescence of these cells directly. FHA may also 
induce the release of inflammatory mediators from neutrophils. 
The effect of FHA on human neutrophil chemiluminescent 
response to fMLP was not investigated.
With a mixture of PT and FHA, the inhibitory effect of PT 
overrode the enhancing effect of FHA on the fMLP-induced 
chemiluminescence of neutrophils. Thus, neutrophil 
bactericidal response would probably be switched off during a 
pertussis infection. FHA had a lag period of about 15 min 
whereas PT had a lag period of about 30-40 min before any
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effect on fMLP-induced chemiluminescence of neutrophils was 
observed. Both PT and FHA are found extracellulariy iji vitro 
and possibly in. vivo. therefore both may act at a distance 
from the site of infection. Thus, although PT takes longer 
than FHA to alter fMLP-induced chemiluminescence, the time 
difference may not be relevant in the in. vivo situation.
FHA has been implicated as a major adhesin of B .pertussis 
and the results presented here suggest that FHA induced the 
generation of bactericidal products from neutrophils. One of 
the functions of PT may be to suppress any neutrophil 
bactericidal responses induced by FHA.
Previously PT has been shown to inhibit neutrophil response 
to fMLP in both human (Lad et , 1905) and rabbit 
neutrophils (Becker ejt al_. , 1905) . Thus, the chemiluminescence
results showing that the toxin had an inhibitory effect on 
fMLP-induced chemiluminescence of rabbit peritoneal 
neutrophils are more easily discussed in terms of the disease 
in humans. Inhibition of neutrophil response to fMLP perhaps 
indicates an inhibition of the normal neutrophil responses to 
infection. Becker e^ t gl_. (1905) suggested that the inhibitory 
effect of PT on the response of different neutrophil species 
to fMLP is closely related to the ADP-ribosylation of a 
G-protein common to the different neutrophil species. The 
chemiluminescence results indicate that PT inhibited the 
fMLP-induced chemiluminescence of rabbit peritoneal 
neutrophils. Although human neutrophils were not assayed, a 
similar inhibitory response would probably be found with these 
cells. Therefore, human neutrophil responses may also be 
inhibited in pertussis infection. In addition, PT induced a 
slight inhibition of the rabbit peritoneal neutrophil 
chemiluminescent response to intact B .pertussis. This would be
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an obvious advantage to the organism iji vivo. Since the 
mechanism of PT-induced inhibition of neutrophil 
chemiluminescence to intact bacteria is unknown, no 
predictions can be made using the results obtained. 
Chemiluminescence studies involving human neutrophils would 
have indicated whether PT also inhibited human neutrophil 
chemiluminescent response to intact B .pertussis .
The studies described in this thesis support the view that 
PT and FHA are important virulence factors of B .pertussis. PT 
is important primarily as the cause of the harmful effects of 
whooping cough (Pittman, 1979) and it may also, as this work 
has shown, inhibit neutrophil bactericidal responses to a 
pro-inflammatory mediator (fMLP) and intact B .pertussis . PT 
may also increase the adhesiveness of neutrophils and thus 
inhibit cell movement. Therefore, PT possibly acts as an 
aggressin by depressing host-defences. FHA, on the other hand, 
appears to enhance the bactericidal response to fMLP which PT
inhibited. However, the inhibitory effect of PT overrode the
enhancing effect of FHA. In addition, FHA may induce a faster 
bactericidal response to intact S .pertussis. If FHA is
essential to the pathogen for lodgement, its apparent
stimulatory effect on neutrophils (which is harmful to the 
pathogen) may be counteracted by PT, and probably by 
B .pertussis adenylate cyclase. It is clear from the above 
that the interaction of B .pertussis with neutrophils is 
complex and that a logical extension of the present work would 
be to investigate ingestion and killing (or survival) of
B . pertussis in the presence and absence of opsonins of various 
specificities. Such studies would produce a better 
understanding of the pathogenesis of pertussis and might find 
applications in development of an improved vaccine.
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APPENDICES
8.1. Media and Diluents
Stainer-Scholte X-mode medium
A modification of the original Stainer and Scholte (1971) 
composition was used.
Chemical Concentration (a 1~^)
1. Monosodium 1-glutamate 10.72
2 . L-proline 0.24
3 . NaCl* 2.50
4 . KHzPO* 0.50
5. KCl 0.20
6 . MgClz. BHseG 0.10
7 . CaCl= 0.02
B . Tris 1 .50
9 . L-cysteine 0.04
10 . FeS04.7HzO 0.01
11 . Ascorbic acid 0.02
12 . Nicotinic acid 0.004
13 . Glutathione 0 .10
Ingredients 1-0 were dissolved in approximately BOO ml of 
distilled water. The pH was then adjusted to 7,6 with 2.5 N 
HCl and the total volume made up to 990 ml with distilled 
water. This preparation was then autoclaved at 121“C for 15 
min at 15 p.s.i. and stored at 4°C until use. Ingredients 9-13 
were dissolved in 10 ml of distilled water, sterilized by 
membrane filtration and then added before use.
♦This was replaced by 5 g of MgS0*.7H=0 for C-mode medium.
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Hb d b s buffered saline CHB5)
Chemical Concentration
NaCl B.OO g
KCl 0.40 g
MgClz,GHzO 0.20 g
CaCl = 0.14 g
Glucose 1.00 g
HEPES 2.300 g
Phenol red id) ml
Ingredients were dissolved in 900 ml of distilled, deionised 
water and the pH adjusted to 7.4 with 1 N NaOH, The volume was 
then made up to one litre with distilled, deionised water and 
the preparation autoclaved at lEl^C for 15 min at 15 p.s.i.
The divalent cation-free HBS-EDTA solution was prepared 
by the omission of the Ca- and Mg-containing salts and the 
addition of 0.292 g of monosodium EDTA.
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Phosphate-buffered saline CDultascco A )
Chemical Concentration
NaCl a  .00
KCl 0  . 2 0
Na=HPO* 1 . 15
KH=PO* 0  . 2 0
Phosphate-buffered saline tablets COxoid) were used. Each 
tablet was added to 100 ml of distilled water and the solution 
autoclaved at 121“C for 15 min at 15 p.s.i. The pH of the 
subsequent solution was 7.3.
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8.2. ELISA buffers
0.05 M Carbonate Buffer
Chemical
Na=CO=
NaHCO=
Concentration Co 1~^)
1 .53
2 .53
Both ingredients were dissolved in one litre of distilled 
water. The pH of the resulting solution was approximately 5.6
PBS-Iween
Chemical
NaCl
KHzPO*
Na=HPO*
KCl
Concentration Co 1~*) 
8.0 
0.2 
1 .15 
0.2
Ingredients were dissolved in one litre of distilled water 
Tween 20 Cpolyoxyethylene sorbitan mono-laurate) was then 
added to a final concentration of 0.05% Cv/v).
: i B
Citrate-Phosphate Buffer
Solution A; 0.1 M citric acid (21.01 g 1“  ^ of distilled 
water).
Solution B: 0.2 M NaaHPO^.PHzO (35.B g 1~^ of distilled 
water).
A 0.15 M solution, pH 5.0, was prepared by the addition of 
45 ml of Solution A to 53 ml of Solution B. The resulting 
solution was passed through a Whatman no. 1 filter paper 
before use (Whatman Ltd., Maidstone, Kent, England).
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B .3 . Buffers and gels for SDS-PAuE
Buffer Per 100 ml
Solubilising Buffer: glycerol 10 ml
mercaptoethanol 5 ml
SOS 3.0 g
Bromophenol blue 0.01 g
Tris buffer CpH G.B)* to 100 ml
♦a 1 in 4 dilution of the upper buffer.
Lower buffer CpH B.IS)^: Tris 18.1 g
SOS 0.4 g
Upper buffer CpH 6.80)^: Tris 6.06 g
SOS 0.4 g
^pH was adjusted using HCl.
Acrylamide / Bis: Acrylamide 30.0 g
Bis 0.8 g
Running buffer CpH 8.3): Tris 0.303 g
glycine 1.44 g
SDS 0.1 g
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Gel
Lower gel CpH 8.13): lower buffer 15 ml
distilled H^O 15 ml
Acrylamide / Bis 30 ml
10% Cw/v) ammonium persulphate 0,30 ml 
TEflED 0.03 ml
Upper gel CpH 6.8): upper buffer 5.0 ml
distilled H^O 12 ml
Acrylamide / Bis 3.0 ml
10% Cw/v) ammonium persulphate 0.05 ml 
TEMED 0.04 ml
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B.4. Standard curves
Figure IS. Cyclic AMP assay standard curve. Co/Cx represents 
the ratio of radioactive label bound in the absence of 
unlabelled cAtlP (Co) over the ratio of radioactive label bound 
in the presence of standard or unknown unlabelled cAMP CCx). 
Each point shown is a mean of 2 observations.
220
Cx
8
6
4
2
8 124 160
pmol Cyclic AMP
Figure gO. Filamentous haemagglutinin ELISA standard curve 
Each point shown is a mean of 2 observations.
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